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PREFACE
Computational biology is still in its infancy. It had not been included in any
college curriculum until the end of last century. That means every young researcher in
computational biology has his/her own story about how to transition to this new field
of study. Here, I would like to share my story about how I become a computational
biologist step by step.
My major in college was pharmaceutical engineering whose curriculum is a com-
bination of chemistry, chemical engineering and pharmacology. At that time, I had
very poor ability to keep tons of chemical reaction formulas in mind, and therefore
gained very little academic achievement in my major. In 2007, I accidentally regis-
tered a course on mathematical modeling when I was a sophomore. The first project
was to use mathematical models to predict the Chinese population in the future. I
still remember I used a logistic regression model to fit the given population data in
the past. As a result, my report received a top grade, which deeply encouraged me
to do something bigger in this field. In that summer, I founded a team with Yuanhai
Xue from computer science and Yongzhuo Li from optoelectronics to participate in
a five-round campus-wide competition in order to represent our college for the inter-
national contest. One of the problems we were given was to design a power supply
network that connects hundreds of villages with minimal lengths. Yuanhai taught
me Kruskal’s algorithm, a classical algorithm in graph theory for finding the minimal
spanning tree in a graph, to solve this problem. This was the beginning of my journey
in graph theory, and eventually led me to my graduate research: using network mod-
els to understand molecular functions and behaviors. Our team was finally awarded
meritorious winner in the international Mathematical Contest in Modeling in 2008,
and the two teammates become my lifelong friends.
vAfter graduating from college, I went to the Academy of Mathematics and Sys-
tems Science in the Chinese Academy of Sciences as a research intern for one year,
under Yong Wang’s supervision. During that time, I utilized the PageRank algorithm
to study the relevance of proteins to Type 2 Diabetes in different tissues. At that
time, I wrote my first PageRank program using a very time-consuming power method.
Two years later, I took David Gleich’s class: Network and Matrix Computation, and
learned how to accelerate PageRank by formulating it as a linear system and solving
it faster by taking advantage of network sparseness. All these experiences benefit
my graduate research in this thesis about how to use PageRank to predict protein
functions and to partition a network into small modules. I suddenly realize that ev-
erything is ultimately interconnected, which reminds me of a speech given by Steve
Jobs at Stanford University in 2005:
“Again, you can’t connect the dots looking forward; you can only connect
them looking backwards. So you have to trust that the dots will somehow
connect in your future. You have to trust in something—your gut, destiny,
life, karma, whatever. Because believing that the dots will connect down
the road will give you the confidence to follow your heart even when it
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ABSTRACT
Jiang, Biaobin Ph.D., Purdue University, August 2016. Computational Labeling, Par-
titioning, and Balancing of Molecular Networks. Major Professor: Michael Gribskov.
Recent advances in high throughput techniques enable large-scale molecular quan-
tification with high accuracy, including mRNAs, proteins and metabolites. Differen-
tial expression of these molecules in case and control samples provides a way to select
phenotype-associated molecules with statistically significant changes. However, given
the significance ranking list of molecular changes, how those molecules work together
to drive phenotype formation is still unclear. In particular, the changes in molecular
quantities are insufficient to interpret the changes in their functional behavior. My
study is aimed at answering this question by integrating molecular network data to
systematically model and estimate the changes of molecular functional behaviors.
We build three computational models to label, partition, and balance molecular
networks using modern machine learning techniques. (1) Due to the incompleteness of
protein functional annotation, we develop AptRank, an adaptive PageRank model for
protein function prediction on bilayer networks. By integrating Gene Ontology (GO)
hierarchy with protein-protein interaction network, our AptRank outperforms four
state-of-the-art methods in a comprehensive evaluation using benchmark datasets.
(2) We next extend our AptRank into a network partitioning method, BioSweeper,
to identify functional network modules in which molecules share similar functions
and also densely connect to each other. Compared to traditional network parti-
tioning methods using only network connections, BioSweeper, which integrates the
GO hierarchy, can automatically identify functionally enriched network modules. (3)
Finally, we conduct a differential interaction analysis, namely difFBA, on protein-
protein interaction networks by simulating protein fluxes using flux balance analysis
xiii
(FBA). We test difFBA using quantitative proteomic data from colon cancer, and
demonstrate that difFBA offers more insights into functional changes in molecular
behavior than does protein quantity changes alone. We conclude that our integrative
network model increases the observational dimensions of complex biological systems,
and enables us to more deeply understand the causal relationships between genotypes
and phenotypes.
11. INTRODUCTION
The whole is greater than the sum of its parts.
—Aristotle (384–322 BC)
1.1 Network as a Language of Functions
A central goal of molecular biology is to understand molecular functions based on
sequences and structures. Sequences determine structures, and structures determine
functions, as a three-layer pyramid from bottom to the top. Sequences are molecular
identifiers indicating who the molecules are; structures are molecular appearances
showing what they look like; and functions are molecular vocations designating what
they do. Ultimately, evolution sheds light on why they do one thing and not an-
other. Understanding molecular functions serves as a genotype-phenotype mapping,
since a phenotype is a product of multiple molecular functions. Mapping genotypes
to phenotypes is not an easy task: one genotype may cause multiple phenotypes,
while one phenotype can originate from multiple genotypes. This many-to-many re-
lationship has been systematically mapped onto the Human Disease Network [1], in
which nodes are either a gene or a disease and edges are gene-disease associations.
The research group in this study published a drug-target network later in the same
year, which displays a similar intertwined relationship between drugs and their tar-
geted proteins [2]. Taken together, this disease-gene-protein-drug network implies
that characterizing molecular functions can close the gap between diseases and drugs
to transform traditional medicine with a one-disease-one-drug paradigm to precision
medicine with accurate diagnosis, personalized treatment, and predictive prevention.
How do molecular biologists investigate molecular functions? Half a century ago,
researchers believed that one gene genetically determines one enzyme that acts with
2one function [3]. This simple concept leads to a reductionist research philosophy,
which has been dominant in molecular biology for a long time. A main reductionist
strategy in experimental design is to study the function of a single gene by deleting
the gene from the genome, and then comparing the phenotypic differences between
the mutant and a wild type control. On one hand, molecular biologists can manipu-
late genomic sequences to investigate the effects of genetic variants of many disease-
associated genes, especially for Mendelian diseases, a.k.a., monogenic diseases. On
the other hand, structural biologists can investigate structural variants of proteins
that cause diseases due to misfolding. However, this strategy fails if the expected
phenotypic difference is masked by compensation of another redundant gene with the
same function as the deleted one [4]. This property of robustness is one of the conse-
quences of evolution, which shapes the survival capability of organisms by exposure
to various deleterious environments, and builds up a living organism as an inseparable
whole. This suggests that a holistic strategy, which considers the living organism as
a whole, or as least as not just a single component, might be an alternative approach
to reductionism.
What is a holistic strategy, and how does molecular functional characterization
benefit from it? By definition, a holistic strategy is to study the interactions of the
multiple components of a complex system as an integrated system, rather than to
break it apart and study each part individually. The idea of holism was introduced
long ago, in the late 1940s, when scientists tried to interpret a systematic cellular
behavior: differentiation [5, 6]. Their question was “how can two cells, having ex-
actly the same genetic material, differentiate into two functionally different cells?”
The scientists interpreted differentiation as a positive feedback circuit in which two
molecules mutually activate each other. This system exhibits the property of bista-
bility : it tends to remain “on” once it is activated, and in contrast, remain “off”
once it is inactivated. This profound concept explains why two differentiated cells
are not interchangeable, and why the process of differentiation is rarely reversible.
Understanding a gene regulatory circuit, or gene regulatory network at large scale,
3implies that understanding systematic cellular behaviors requires deep knowledge of
the complex interconnections between macromolecules, which brings up an emerging
field of study: systems biology.
The aim of systems biology is to study how complex interconnections between
macromolecules give rise to emergent cellular behaviors. There are no stringent defi-
nition of the scale and boundaries of a biological system. And therefore, a system can
be either as small as a signaling pathway, or as large as a whole organism. At local
levels, for instance, when one studies the function of a single transmembrane receptor
in detail, it can be beneficial to have a functional understanding of the binding ligands
in upstream and downstream signaling cascades in the pathway [7]. At intermediate
levels, a well-known example is the biochemical network in which nodes are metabo-
lites and edges represent biochemical reactions. Systems biologists use flux in the
biochemical network to denote reaction rates, and construct a linear programming
model called flux balance analysis (FBA, [8]) to simulate a steady state, or equilib-
rium, of the total network flux [9]. At the whole-cell level, the task becomes more
challenging since systems biologists need to consider not only a homogeneous network
wherein nodes are the same type (e.g., a metabolic network), but also a heterogeneous
network wherein nodes are of more than one type (e.g., transcription factors and their
targeted DNA sequences), or even networks of networks when simulating the entire
cell cycle [10].
Studying biomolecular networks can benefit pathology research by elucidating the
consequences of genetic variants. As mentioned above, the Human Disease Network
implies that dysfunction of one gene may result in multiple different diseases, and con-
versely, one multigenic disease may result from multiple genes. A common dilemma in
the study of disease-associated genotypes is that identical genetic variants are rarely
found across multiple patient samples with the same phenotype [11]. To this end,
Ciriello et al. proposed a computational method, called MEMo (Mutual Exclusivity
Modules), to identify highly recurrent genetic variants in the same biological process
(i.e., functional module, a subset of a biomolecular network) that are mutually exclu-
4sive between different patients [12]. They claimed that, even though those variants
are not commonly found in all patients, they alter the same biological process, and
therefore, result in the same phenotype. Another example of using computational
network biology methods to address this dilemma is to infer tumor evolutionary tra-
jectories that illustrate which genetic variants drive the occurrence of others [13].
This method infers sequential networks between variants from longitudinal data, and
then performs network integration across different patient samples and uses network
deconvolution to determine a final resulting trajectory. Besides tumor heterogene-
ity, systems biologists also study the effects of genetic variants using protein-protein
binding interface data to increase the resolution of network interactions [14]. In a
profound study, Zhong et al. proposed a novel concept, namely edge-specific genetic
perturbation (edgetic perturbation) to denote a set of genetic variants that specifically
disrupt protein-protein interactions [15]. This study for the first time systematically
demonstrates how disease-associated variants cause loss of function at protein struc-
ture resolution (see Chapter 1.4.1 for details).
Given the effects of disease-associated genetic variants, as seen through the lens of
network data, systems biologists next seek a systematic treatment capable of restor-
ing the perturbations of those effects, which gives rise to a new field of study, namely
systems pharmacology or network medicine [16, 17]. To effectively develop drugs
targeting complex diseases, we may need to rewire signaling networks perturbed by
multiple genetic variants using a combinatorial treatment strategy. Irish et al. uti-
lized single-cell flow cytometry to monitor signaling activities of phospho-proteins,
and showed that there is dramatic remodeling of signaling networks between healthy
and acute myeloid leukemia patient samples [18]. Komurov et al. investigated a
set of breast cancer cells that are resistant to lapatinib treatment, an EGFR/ErbB2
inhibitor, and found that those cells receiving the treatment overly upregulate the
glucose deprivation network [19]. They next treated those cells with other drugs tar-
geting this network, which significantly reduces the survival rate of those resistant
cells. Furthermore, Lee et al. investigated this EGFR inhibition using a combina-
5torial treatment strategy as well, and found that a sequential treatment of multi-
ple anticancer drugs, rather than simultaneous treatment, significantly enhances the
treatment effect of rewiring apoptotic signaling networks [20]. These successful ex-
amples suggests that modeling molecular networks can guide the design of multi-drug
combinatorial treatment to cure complex diseases caused by multiple genetic variants.
In summary, I have given a brief introduction to network biology, and how it en-
hances our understanding of multigenic diseases and provides therapeutic clues in the
development of combinatorial treatment. I next will further introduce how to con-
struct a molecular network via high throughput techniques, and how to computation-
ally analyze network topological structure, and its dynamics in disease progression.
1.2 Network Construction
A molecular network consists of multiple molecules and their interactions. In this
section, I will introduce several primary high throughput techniques for molecular
quantification and measurement of their interactions. In addition, I will introduce
computational methods for inference of virtual networks that cannot be measured
directly via experimental techniques.
1.2.1 Molecular Quantification
Proteins are primary functional units in a cell. Researchers are dedicated to de-
veloping a collection of qualitative and quantitative techniques to determine which
protein exits in the cell and how many copies it has. These techniques includes cel-
lular imaging, electron microscopy, array and chip platforms, and mass spectrometry
(MS) [21]. Unlike the other methods, mass spectrometry is a de novo analytic tech-
nique that examines complex protein populations, and it has been widely used in
pharmaceutical development, disease diagnosis and food safety control. In 2002, the
Nobel Prize in chemistry was jointly rewarded to John B. Fenn and Koichi Tanaka
for their exceptional contribution to the development of molecular ionization in mass
6spectrometry. A generic mass spectrometry experiment consists of five steps [21]: (1)
isolate the proteins to be analyzed from cells or tissues; (2) digest the proteins to pep-
tides by trypsin; (3) ionize the peptides by electrospray or soft laser desorption; (4)
collect the mass/charge spectrum of the peptides; and (5) process the spectrum and
match the peaks against protein sequence databases to determine the identity of the
peptides. MS studies quickly go beyond qualitative to quantitative measurements,
enabling comparison of the same peptide under different experimental conditions.
Stable-isotope labeling by amino acids in cell culture (SILAC) tags peptides with
stable isotopes, such as 13C, 15N and 2H, to produce predictable mass differences
between peptides from two conditions [22]. Another quantitative method is targeted
MS techniques, e.g., Selected reaction monitoring (SRM) [23,24]. This method mon-
itors particular ions (ionized peptides) of an a priori known protein throughout a
tandem MS measurement over time, which enables the detection of low-copy number
proteins, and the quantitative study of its signaling behaviors.
Although detection and quantification of low-copy proteins is challenging [25],
and proteome-wide measurement based on current proteomic protocols are highly
laborious, large-scale proteome-wide measurements are technically possible for model
organisms, and even for human cells. Kim et al. introduced a draft map of the human
proteome using high-resolution Fourier-transform mass spectrometry [26]. Uhle´n et
al. presented a map of the human tissue proteome including 44 major tissues and
organs in the human body using the integration of transcriptomics and antibody-
based proteomics [27]. The Cancer Proteome Atlas project has generated protein
expression data for many tumor samples using reverse-phase protein arrays (RPPAs),
which provides researchers with an insightful functional landscape of cancer proteomes
[28].
In addition to proteins, messenger RNAs (mRNAs) can also be measured in a high
throughput manner. RNA sequencing is a powerful technique for accurately measur-
ing gene expression at single-base resolution, and identifying different isoforms as
well [29]. Briefly, it first converts a long mRNA into a complementary DNA (cDNA),
7and then fragments the cDNA into short sequences. After adding adaptors to the
two ends of each sequence, it utilizes high-throughput next-generation sequencing
technology to obtain the sequence of each cDNA fragment, a.k.a. reads. These reads
then can be mapped back to the reference genome, or are assembled together into
longer contigs in a de novo manner for species without reference genomes. The key
computational analysis in this RNA-seq transcriptomics pipeline is to accurately map
the reads to reference genomes. Numerous computational tools for RNA-seq assem-
bly and quantification have been developed in the past decade. A comprehensive
assessment has been conducted to evaluate the performances of 14 independent com-
putational methods using benchmark datasets [30]. It turns out that the current tools
can successfully identify transcript components with high accuracy, whereas accurate
identification of complete isoform structures still needs further improvement due to
the tremendous combinations of exons. Recently, a new ultra-fast method, namely
kallisto, has been proposed to quantify gene expression level from RNA-seq reads data
using pseudoalignment to avoid base-to-base exact alignment of reads to a reference
genome [31]. Experimental tests using both simulated and real datasets show that
kallisto achieves comparably accurate quantification with other four state-of-the-art
methods, but shortens the computational time by nearly 10 to 400 fold.
Another large class of biomolecules are metabolites. Metabolites can be mea-
sured and quantified using liquid chromatography and flow injection analysis-mass
spectrometry [32]. One computational analysis in metabolomics is to first identify
the associated proteins (e.g., enzymes) of the metabolites in the Human Metabolome
Database (HMDB) [33] , and then to analyze the regulatory pathways at the pro-
tein level. This method is suitable for small-scale studies of hundreds of metabolites.
Another method for large-scale studies is to reconstruct a metabolic network from
thousands of biochemical reactions, which usually requires community efforts [34].
The reconstruction of the global human metabolic network enables computational
analysis of each reaction rate using FBA, under the balanced assumption that the
8current concentration of one metabolite is equal to the produced amount minus the
consumed amount.
Ultimately, systems biologists expect to comprehensively model and analyze the
physiological states of an individual using multi-omics data to fulfill the mission of
personalized medicine. Chen et al. presented an integrative personal omics profile
(iPOP) including genomic, transcriptomic, proteomic, metabolomic, and autoanti-
body profiles of an individual during 14 months [35]. This extensive study is the
first attempt to monitor an individual’s health using multi-omics data, and uncovers
various potential disease risks for useful guidance of prevention in advance.
1.2.2 Interaction Measurement
In order to understand the emergent properties of complex biological systems,
measuring molecular quantities alone is insufficient, since a biological system does
not run via simple summation of individual molecular functions, but via collective
behaviors mediated by molecular interactions.
The primary macromolecular interaction is protein-protein physical interactions
since proteins are the primary functional units in a cell. In 1989, Fields and Song
invented the yeast two-hybrid (Y2H) assay to successfully measure binary protein-
protein interactions [36]. The Y2H concept makes use of a reporter gene in yeast
for detecting the interaction of pairs of proteins inside yeast cell nucleus. First, a
bait protein and a prey protein are fused to a DNA-binding domain and a transcrip-
tional activation domain of a transcription factor (e.g., Gal4) via DNA recombination
techniques, respectively. Then if the bait protein binds to the prey protein, the two
domains of the transcription factor are linked to activate the expression of a reporter
gene (LacZ, encoding enzymes of galactose utilization) [36]. After a decade, two re-
search groups in 2000 presented large-scale Y2H screens identifying protein-protein
interactions in Saccharomyces cerevisiae (budding yeast) [37] and Caenorhabditis el-
egans (a roundworm) [38]. Giot et al. in 2003 and Rual et al. in 2005 used Y2H to
9systematically map the first large-scale Drosophila melanogaster (fruit fly) and human
protein interactomes, respectively [39,40]. With continuous refinement and efficiency
improvement of the Y2H assays, researchers successfully map at larger scales the pro-
tein interactomes of S. cerevisiae in 2008 [41], C. elegans [42] and humans in 2014 [43].
Vo et al. presented a proteome-wide binary protein interactome for S. pombe (fission
yeast) comprising 2,278 interactions, conducted cross-species analysis of protein in-
teractomes, and identified more evolutionarily conserved interacting proteins between
S. pombe and humans, other than S. cerevisiae [44]. Marc Vidal and Stanley Fields
reviewed the history of Y2H from 1989, when Y2H was invented, to 2014 [45], and
estimated that, so far, about 10,000 high-quality binary protein-protein interactions
have been mapped, which accounts for less than 10% of the total protein interactome
in human.
Another technology for measuring protein-protein interactions is affinity purification-
mass spectrometry (AP-MS). This method is mainly used to measure interactions of
multi-protein complexes, the stoichiometry of the protein subunits, and dynamics of
the protein-complex assemblies [46]. In 1999, Bertrand Seraphin and his colleagues
developed the first AP-MS protocol in yeast [47]. The basic idea of AP-MS is first
to use an affinity reagent to purify a protein complex from a protein lysate, and then
to identify the subunits of the purified complex by MS. Some protein complexes with
a large number of subunits need to be purified multiple times using tandem affinity
purification (TAP) tags. Gavin et al. and Krogan et al. used the TAP-tag approach
followed by MS to comprehensively identify high-confidence interactions of protein
complexes in yeast [48, 49]. Hutchins et al. used AP-MS approach to systematically
identify human protein complexes during chromosome segregation [50]. Havugimana
et al. identified 622 human soluble protein complexes comprising 3,006 proteins and
13,993 high-confidence physical interactions [51]. The key difference between AP-MS
and Y2H is that AP-MS only gives a list of proteins physically associated with the
bait protein. How those subunits of protein complexes bind to each other cannot be
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specified by AP-MS. That is why the interactions identified by Y2H are called binary
interactions.
In addition to identification of protein-protein interactions by Y2H and AP-MS in
single species, systems biologists utilize various high throughput techniques to identify
protein interactions between different species, or interactions of proteins with other
biomolecules. Rozenblatt-Rosen et al. used Y2H to map the interactions between tu-
mor virus proteins and host proteins, and found that tumor virus proteins systemati-
cally perturb the host interactome [52]. Breitkreutz et al. used MS-based approaches
to identify a kinase and phosphatase interaction (KPI) network comprising 1,844 in-
teractions in budding yeast [53]. Saliba et al. presented a liposome microarray-based
assay (LiMA) to systematically characterize protein-lipid interactions [54]. Gu et al.
invented a novel method for detecting protein-protein interactions by taking advan-
tage of powerful DNA sequencing technology [55]. Their single-molecule-interaction
sequencing (SMI-seq) attaches DNA barcodes to proteins so that the DNA barcodes
can next be amplified, sequenced and quantified by next-generation sequencing (NGS)
technology. To understand transcriptional regulation via binding of transcription fac-
tors and their direct targeting of DNA sequences, Johnson et al. presented a high
throughput method called chromatin immunoprecipitation followed by sequencing
(ChIPseq) for performing genome-wide mapping of protein-DNA interactions [56].
All these experimental methods aim to generate a global map of biomolecules, which
serves as the basis for further modeling and analysis of complex biological processes.
1.2.3 Virtual Network Inference
The biomolecular networks mapped by high throughput experimental assays are
still incomplete, and therefore, computational systems biologists attempt to construct
computational models to predict the interactions that have not been mapped by the
experimental assays using partially known interactions in current databases. Zhang
et al. devised a computational approach to predict protein-protein interactions using
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three-dimensional structural information [57]. La and Kihara presented a phylo-
genetic framework, namely BindML, to predict protein-protein binding sites using
information from evolutionary conservation [58].
Another example of biological network inference is the identification of gene reg-
ulatory networks (GRNs). The interactions are “virtual”, which means that those
interactions do not necessarily imply a physical interaction between two genes, rather
than indirect interactions that arise from correlated patterns of gene expression [59].
Bansal et al. presented a comprehensive review on gene network inference algo-
rithms, and divided them into four classes: coexpression and clustering, Bayesian
networks (BNs), information-theoretic approaches, and ordinary differential equa-
tions (ODEs) [59]. Calculating Pearson correlation coefficients (PCCs) between each
pair of gene profiles is a straightforward method to construct a gene network. This
analytical framework is normally followed by a hierarchical clustering analysis to
group genes with similar expression profiles [60,61]. BNs are a graphical presentation
of the joint multivariate probability distribution that captures conditional indepen-
dence between random variables. Friedman et al. first constructed a BN to analyze
gene expression data in yeast, and successfully inferred several gene interactions that
are supported by biological evidences [62]. Information-theoretic approaches rely on
a statistical metric called Mutual Information (MI), which measures the degree to
which one random variable is non-randomly associated with another. Butte and Ko-
hane used MI to construct a relevance network using 79 expression measurements of
2,467 genes in yeast, and then detected 22 clusters of genes with significant biological
relevance [63]. ODEs are normally used to model time-series expression data without
considering statistical dependencies, in contrast to BN or MI. D’Haeseleer et al. used
ODEs to infer gene interactions given the expression of 65 genes at 28 time points,
and demonstrated how to use the resulting network to generate hypotheses and direct
further experiments [64]. To accelerate the development of novel methods for gene
network inference, systems biologists organized the Dialogue on Reverse Engineering
Assessment and Methods (DREAM) project, and integrated the inferred networks
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from over 30 methods to produce a high-confidence network [65]. They further ex-
perimentally tested the ensemble network, and showed that 23 out of 53 previously
unreported interactions are supported by the experimental evidences.
To understand the properties of emergence and robustness of biological systems,
systems geneticists study the functional dependency of two genes by examining whether
the effects of simultaneously knocking out two genes is equal to the sum of the ef-
fects of the individual knockouts. This kind of functional dependency is referred to
as genetic interaction, or epistasis [66]. Tong et al. presented a high throughput
assay, termed synthetic genetic array (SGA) to systematically map the genetic inter-
action network in yeast comprising 204 genes and 291 interactions in 2001 [67]. They
continuously conducted the assays for a larger scale mapping of the yeast genetic
interactions including about 1,000 genes and 4,000 interactions later in 2004 [68]. In
2010, they finally created a global reference map for the yeast genetic interaction net-
work comprising 5.4 million gene-gene pairs using high throughput double knockout
assays [69]. Bandyopadhyay et al. further perturbed the yeast genetic interaction
network with a DNA-damaging agent, and found that the network rewires to adapt
to the external perturbation [70]. Another team utilized an RNA interference (RNAi)
strategy to comprehensively map the genetic interaction network in mammalian cells,
and created a functional map of chromatin complexes in mouse fibroblasts [71]. Those
extensive maps of functional dependency serve as a basis for system biologists to fur-
ther understand functional organization and adaptive properties of a cell.
1.3 Network Topology
Given a network, scientists have defined many topological properties from different
perspectives. Here, I will briefly introduce three basic network concepts: centrality,
distance, and modularity, and their applications to biological networks. In particular,
built on these three basic concepts, network scientists introduce the three most robust
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measures of network topology: degree distribution, average path length and clustering
coefficient.
1.3.1 Centrality
The first and most straightforward network property is degree, the number of
connections (neighbors) that a node has in a network. Mathematicians and statistic
physicists attempted for a long time to find a probability distribution to fit the degree
distribution of a network. In 1959, the Hungarian mathematicians Erdo˝s and Re´nyi
proposed a pure random network model with the assumption that each connection
(or edge) appears with equal probability, and is independent of any other connec-
tions [72]. This model produces a binomial distribution of network degree, or Poisson
distribution in the limit of large number of nodes. However, Baraba´si et al. reported
in 1999 that most real-world networks, such as the internet and social networks,
follow a power-law distribution P (k) ∼ k−γ with 2 < γ < 3 [73], rather than the
Poisson distribution in the classical Erdo˝s-Re´nyi model. They named the networks
following this power-law distribution scale-free networks, in the sense that the second
(variance) and higher moments of the power-law distribution are infinite when γ < 3,
and hence these networks lack a characteristic scale. In this type of network, a small
set of nodes have high degree, whereas the majority of nodes have low degree. They
explained this phenomenon by proposing a rule of network growth called preferen-
tial attachment : a new node prefers to attaching to the nodes with higher degree,
called hubs in the network [73]. This principle is commonly known as “the rich get
richer”. Several years later, many researchers showed that protein-protein interaction
networks are scale-free, following a power-law distribution [39–41, 49], even though
this statement is currently still in debate [74, 75]. These hub proteins were later
found to be essential in yeast: knockouts of hub genes frequently lead to lethality,
compared to non-essential genes/proteins with fewer links, whose removals are non-
lethal and tolerable [76]. Han et al. further defined two types of hubs: party hubs,
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which interact with their partners at the same time and location, and date hubs,
which bind their neighbors at different times or locations [77]. By computationally
removing nodes to identify their topological importance, they found that both types
of hubs are indispensable to connectivity of the whole network, and date hubs are
even more significantly important than party hubs. Taylor et al. extended this con-
cept into intramodular hubs and intermodular hubs, and found that besides their
topological importance, intermodular hubs have more signaling domains and more
cancer-associated mutations than intramodular hubs [78].
1.3.2 Distance
The second basic network measure is the topological distance between two nodes
in a network. In a connected network without any isolated “islands”, one node can
reach any other node through many possible paths. Among these paths, the shortest
one is widely used to define the distance between two nodes. Occasionally, there may
be multiple shortest paths between two nodes with equal lengths. In the simplest
network, one without weights and directions on edges, the length of the shortest path
between two nodes is defined as the number of the traversed edges connecting the
source node, destination node and intermediate nodes along the path. Given a net-
work, finding the shortest path between two nodes is a classical problem in graph
theory. The classical algorithm to find the shortest path, given a single source node
to any other nodes, is Dijkstra’s algorithm [79]. This algorithm, in fact, adopts the
idea of dynamic programming: it finds the shortest path from source node to each
intermediate node at each iteration. This strategy breaks down an optimization prob-
lem into several sub-problems, and the optimality of the solution to each sub-problem
can be guaranteed according to the Principle of Optimality which was proposed by
Richard E. Bellman in 1952 [80].
Many other network characteristics are built on the shortest path. One of them is
average path length, a.k.a., characteristic path length (CPL), defined as the average
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length of all pairwise shortest paths in a network. CPL is widely used to characterize
the small-world phenomenon [81], popularly known as six degrees of separation [82].
Watts and Strogatz used CPL and clustering coefficient (see Chapter 1.3.3) to char-
acterize three real-world networks [83], and reported that the small-world networks
have longer CPL than the random networks (generated by the Erdo˝s-Re´nyi model),
but smaller clustering coefficients than in lattice networks where each node connects
to its k nearest neighbors. In particular, a small-world network is defined as a net-
work whose CPL, termed L, increases proportionally to the logarithm of the number
of nodes N in the network, i.e., L ∝ logN . Telesford et al. proposed a unified small-
world measurement ω = Lrand/L − C/Clatt where C denotes clustering coefficient
and the subscripts “rand” and “latt” indicate random networks and lattice networks,
respectively [84]. CPL is widely used to quantify the topological importance of one
node in retaining the small-world property. A node is topologically important in re-
taining the small-world property if its removal increases the CPL of the network. As
mentioned previously, Taylor et al. used the change in CPL to show that intermodu-
lar hubs are more important in retaining the small-world property than intramodular
hubs [78].
Another network characteristic built on shortest paths is betweenness centrality,
another widely used centrality measure. The betweenness centrality of a node in a
network is defined as the number of all pairwise shortest paths that pass through that
node [85]. A node with high betweenness centrality is analogous to a bridge between
two big cities. And every time people would like to travel from one city to the other,
they have to pass through the bridge. Proteins with high betweenness are likely to
be essential: knocking out those genes tends to result in lethality [86]. Furthermore,
proteins with high betweenness but low degree tend to have low expression correlation
with their neighbors [86]. These proteins are likely to be key regulators in cross-
talk between two pathways. For example, cyclin-dependent protein kinase-activating
kinase 1 (CAK1) gene, encodes the protein Cak1p, which regulates two key signaling-
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transduction pathways: the mitotic cell cycle, and the MAP kinase pathway which
regulates spore morphogenesis in yeast [86].
1.3.3 Modularity
A third network topological property is clustering coefficient, an indicator of mod-
ularity that partitions a global network into densely connected subnetworks. Even
though a holistic strategy attempts to investigate all molecules and their connections
as a whole, a global network sometimes may be too large to be analyzed without loss
of details. Partitioning a large network into several relatively independent modules
is a feasible compromise.
There are two different clustering coefficients: global clustering coefficient (GCC)
and local clustering coefficient (LCC). GCC is a characteristic of a network. Define
a triplet as three connected nodes in a network. A closed triplet is three nodes that
are fully connected by three edges, whereas an open triplet is three nodes that are
connected by two edges, without connection between one pair of nodes (open). Three
nodes in which one node lacks of connection are not considered to be a triplet. In 1949,
Luce and Perry defined GCC as the ratio of number of closed triplets over the total
number of triplets (both open and closed) [87]. GCC ranges from 0, indicating no
triplets, to 1 for a fully connected network. Similarly, LCC is a characteristic of nodes
in a network. LCC is defined as the ratio of number of edges between the neighbors
of a node over all possible edges between these neighbors. That is, a node having
k neighbors will have (k − 1)k/2 possible edges for the case of undirected networks.
A node whose neighbors are not connected to each other, like a spoke, will have an
LCC of 0, whereas a node with a fully connected neighborhood will have an LCC of
1. As mentioned previously, Watts and Strogatz defined a small-world network using
CPL and average LCC of all nodes, and demonstrated that a small-world network
has significantly higher average LCC than a random network [83].
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Biological systems have proven to be modular [88]. Clustering coefficients can
only indicate whether a network is modular, and therefore, automatically finding func-
tional modules in biological networks has become a long-term goal in systems biology.
Ravasz et al. decomposed the metabolic networks of 43 distinct organisms into several
small but densely connected modules using an average-linkage hierarchical clustering
algorithm [60], and showed that those metabolic networks have higher average LCC
than module-free networks [89]. Girvan and Newman reviewed the shortcomings of
traditional hierarchical clustering methods in finding network modules. Based on this,
they proposed an alternative method using edge-betweenness [90]. They defined the
edge-betweenness of an edge as the number of pairwise shortest paths traversing that
edge divided by the number of all-pair shortest paths. And then they detected mod-
ules by sequentially removing the edges with high edge-betweenness. They further
proposed modularity, a score for quantifying the quality of functional modules [91].
It is defined as the observed number of edges within a module minus the expected
number of edges within the module. Assuming that each edge appears uniformly at
random, the expected number of edges between node i and j can be estimated as
kikj/2m, where ki and kj are the degrees of nodes i and j, and m is the total number
of edges in the network. Newman later proposed a spectral algorithm to maximize the
modularity score, and demonstrated that the proposed algorithm can detect better
modules with larger modularity scores than other modularity-based methods [92].
This problem has also gained the attention of computer scientists, since module
detection has become a general task not only in biological networks, but also social
networks and others. Fortunato gave a comprehensive review on the progress of this
study [93].
1.4 Network Dynamics
Network topology is primarily applied to characterizing static networks. However,
biological networks in many cases are not static, but dynamic [94]. Even though
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high-throughput experimental technology for the interrogation of biological network
dynamics is still limited, accumulating evidence shows that biological networks rewire
when perturbed by genetic variants, or changes of post-translational modification
(PTM). Time-dependent molecular quantification can reveal quantitative changes in
interaction frequency and strength in signaling pathways. In this section, I will briefly
review experimental and computational techniques for examining biological network
rewiring and dynamics.
1.4.1 Edgetic Perturbation
As mentioned in Chapter 1.1, the concept of edgetic perturbation sheds light on
how genetic variants located in protein-protein binding interfaces disrupt specific
interactions rather than the entire protein structure [15]. Dreze et al. presented
an integrated method using the reverse Y2H system to systematically characterize
edgetic alleles of the gene CED-9, whose mutations can alter its protein-protein inter-
actions and result in different phenotypes in C. elegans [95]. Wang et al. investigated
62,663 genetic variants and their disruptive effects on 4,222 high-quality binary human
protein-protein interactions, and showed that different mutations in the same protein
can cause distinct disorders by altering different interactions [96]. In 2015, Sahni et
al. published a more comprehensive investigation with over 100,000 disease-associated
variants, and systematically characterized the effects of those human disease missense
mutations into two classes: protein folding/stability changes and protein interaction
perturbations [97]. In 2016, Yang et al. conducted a large-scale investigation on how
alternative splicing alters protein interactions, and demonstrated that besides genetic
mutations, different isoforms made by different combinations of exons, interact with
distinct functional partners in a tissue-specific manner [98]. This research team, led
by Marc Vidal at the Dana-Farber Cancer Institute, claimed in one review article
that the study of edgetics provides an insightful way to partially interpret genotype-
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to-phenotype relationships as the loss or gain of protein interactions [99]. And they
named these edgetics-associated phenotypes as edgotypes.
Enlightened by the concept of edgetics, systems biologists have further explored
how genetic mutations alter signaling networks, e.g., phosphorylation-dependent in-
teractions between kinases and their substrates. Rune Linding and his colleagues
developed a computational method named KINspect to predict which amino acids in
the kinase domain determine substrate specificity [100], and then presented a compu-
tational framework called ReKINect, to analyze how genetic mutations of those alle-
les, termed network-attacking mutations, rewire phosphorylation-dependent signaling
networks leading to the associated phenotypes such as cancers [101]. AlQuraishi et al.
described an analytic framework based on multiscale statistical mechanics (MSM) to
estimate the effects of genetic mutations on the SH2 domains of human kinases, and
showed how those cancer-associated mutations mediate signaling pathways by acti-
vating or disrupting interactions [102]. All these studies demonstrate that the concept
of edgetics is not only applicable to common protein-protein physical interactions, but
also kinase-substrate transient interactions.
1.4.2 Temporal Dynamics
In addition to genetic mutations and PTMs, many other factors can alter molec-
ular interactions, such as molecular abundance, binding affinity, binding ratio (stoi-
chiometry), conditional regulation and so on. With the advance of high-throughput
molecular quantification during the past five years, it has become feasible to sys-
tematically quantify macromolecular abundance over time, even at the single-cell
level. In 2011, Tony Pawson and his colleagues designed an MS-based method named
AP-SRM, to quantify the changes in protein interactions with GRB2 (growth factor
receptor bound protein 2), an adaptor protein in the downstream of the epidermal
growth factor receptor (EGFR) pathway [103]. They successfully totally identified
90 proteins interacting with GRB2 in HEK293T cells at five different time points
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after stimulation of cells with epidermal growth factor (EGF). This GRB2-centered
protein-interaction network displays a time-dependent map comprising upregulated,
downregulated, and unchanged interactions, and reveals the dynamic signaling be-
haviors from stimulation to activation of effectors.
In 2013, Ruedi Aebersold and his colleagues proposed another MS-based method,
called affinity purification combined with sequential window acquisition of all theo-
retical spectra (AP-SWATH), to investigate how the 14-3-3β scaffold protein changes
its interaction frequency with its binding partners after stimulation by insulin-like
growth factor 1 (IGF1) [104]. Lambert et al. at the same time developed the corre-
sponding statistical analysis pipeline for AP-SWATH, and applied it to investigating
the dynamics of another protein interactome centered at CDK4 (cyclin-dependent
kinase 4) under three different conditions: wild type, two mutants R24C and R24H,
and treatment by NVP-AUY922, an experimental drug candidate for cancers [105].
In 2014, Dana Pe’er, Garry Nolan and their colleagues pushed the study of molec-
ular interaction dynamics forward to single-cell resolution [106]. They utilized mass
cytometry, combined with the statistical models, to establish quantitative estima-
tion of signaling interaction strengths and the resulting signaling response functions
in na¨ıve and antigen-exposed CD4+ T lymphocytes. They also experimentally val-
idated their estimated interaction strengths and demonstrated the utility of their
method in systematically mapping quantitative signaling networks.
1.5 Thesis Road Map
In this thesis, I develop three computational tools to investigate three topics in
network biology: labeling, partitioning, and balancing molecular networks. Due to the
incompleteness of protein functional annotations, I develop AptRank, a classification-
based method, to integrate molecular network data to predict protein functions.
With full molecular functional profiles, I next develop BioSweeper, a clustering-based
method, to partition the networks into functional modules in which molecules share
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similar functions. Finally, I develop difFBA, a linear-programming-based method to
estimate the balanced state of protein fluxes throughout the network, and compare
the balanced states using proteomic data from healthy and colon cancer samples. The
organization of the three thesis projects is outlined in Table 1.1.
Table 1.1
Thesis Outline
Chapter Topic Aim Tool
2 network labeling protein function prediction AptRank
3 network partitioning functional module detection BioSweeper
4 network balancing differential flux balance analysis difFBA
At the end, I briefly describe two side projects in Chapter 5, and summarize all
the works in Chapter 6.
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2. NETWORK LABELING: PROTEIN FUNCTION
PREDICTION
Diffusion-based network models are widely used for protein function prediction
using protein network data and have been shown to outperform neighborhood-based
and module-based methods. Recent studies have shown that integrating the hierar-
chical structure of the Gene Ontology (GO) data dramatically improves prediction
accuracy. However, previous methods usually either used the GO hierarchy to refine
the prediction results of multiple classifiers, or flattened the hierarchy into a function-
function similarity kernel. No study has taken the GO hierarchy into account together
with the protein network as a two-layer network model.
We first construct a Bi-relational graph (Birg) model comprising protein-protein
association and function-function hierarchical networks. We then propose two diffusion-
based methods, BirgRank and AptRank, both of which use PageRank to diffuse infor-
mation on this two-layer graph model. BirgRank is a direct application of traditional
PageRank with fixed decay parameters. In contrast, AptRank utilizes an adaptive
diffusion mechanism to improve the performance of BirgRank. We evaluate the abil-
ity of both methods to predict protein function on yeast, fly, and human protein
datasets, and compare with four previous methods: GeneMANIA, TMC, Protein-
Rank and clusDCA. We design three different validation strategies: missing function
prediction, de novo function prediction, and guided function prediction to compre-
hensively evaluate predictability of all six methods. We find that both BirgRank and
AptRank outperform the previous methods, especially in missing function prediction
when using only 10% of the data for training.
AptRank naturally combines protein-protein associations and the GO function-
function hierarchy into a two-layer network model without flattening the hierarchy
into a similarity kernel. Introducing an adaptive mechanism to the traditional, fixed-
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parameter model of PageRank greatly improves the accuracy of protein function pre-
diction. All the datasets and Matlab codes are available in our GitHub repository at
https://github.rcac.purdue.edu/mgribsko/aptrank.
2.1 Introduction
Given a set of functionally uncharacterized genes or proteins from a Genome-
Wide Association Study, or differential expression analysis, experimental biologists
often have little a priori information available to guide the design of hypothesis-based
experiments to determine molecular functions. For example, what is the expected
phenotype if a particular gene is removed? It would greatly improve hypothesis
formation if biologists had prior insight from predicted functions of interesting genes or
proteins in databases. Computational annotation of genes or proteins with unknown
functions is thus a fundamental research area in computational biology.
In the past decade, there has been much work to accurately predict functional
annotations of genes or proteins using heterogeneous molecular feature data [107,
108]. The collected molecular features include gene expression, sequence patterns,
evolutionary conservation profiles, protein structures and domains, protein-protein
interactions (PPIs), and phenotypes or disease associations. In one comprehensive
assessment [107], one of the methods, GeneMANIA [109] slightly outperformed the
other eight methods by integrating the multiple molecular features into a functional
association network (a.k.a., a kernel). The success story of GeneMANIA suggests two
important ideas. First, we can significantly improve prediction methods that rely on
a single data type by integrating data of many types. And second, kernel integration
is a particularly powerful approach to combining multiple types of data.
Given an integrated functional association network, methods for protein function
prediction can be divided into three different types: neighborhood-based, module-
assisted, and diffusion-based [110]. Neighborhood-based methods [111] predict the
function of one protein by using the functions of its neighbors in the network, i.e.,
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the guilt-by-association approach. This approach has two obvious drawbacks. On
one hand, it ignores the functional information from all the other proteins outside the
neighborhoods of the query proteins, which leads to a low true-positive rate. On the
other hand, it may also have high false-positive rates when the query protein has a
single function but is surrounded by many multi-functional proteins.
Module-assisted methods operate by first partitioning a network or a kernel into
functional modules [112,113]. Biologically, a functional module in a PPI network is a
group of physically interacting proteins engaged in a biological activity, e.g., to form
a scaffold or to relay signals. In network science, a good module is commonly defined
as a densely connected subgraph with loose connections to the outside [91]. This
definition is naturally coincident with protein complexes, but not signaling cascades.
Obtaining a high-quality graph partition is challenging, and this field of study is still
highly active.
Diffusion-based methods generally simulate propagating information from func-
tionally known proteins to unknown ones through network connectivity. Nabieva et
al. [114] constructed a network flow model with fixed diffusion distances and capacities
on network edges. This method was claimed to capture both global network topology
as well as local network structure to improve the function predictability over the first
two domains of methods mentioned above. Freschi devised a tool called ProteinRank
by utilizing PageRank [115], the method used by Google to rank webpages, to dif-
fuse functional annotation information throughout a network without setting a fixed
diffusion distance or edge capacities [116]. Mostafavi et al. utilized the Label Prop-
agation algorithm [117] to develop GeneMANIA [109] as a classification model with
multiple heterogeneous network datasets using weighted kernels and labeled negative
samples. The method achieved approximately 70 ∼ 90% accuracy in three-fold cross
validation using a benchmark dataset [107]. Yu et al. [118] developed the Transduc-
tive Multilabel Classifier (TMC), based on a Bi-relational graph [119] consisting of
a protein interactome and cosine similarities in a protein functional profile as two
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kernels in each graph layer. Then they used PageRank on this two-layer graph to
diffuse functional information to predict protein functions.
Functional annotation data are usually organized in a tree-like ontological struc-
ture with general terms at the root and specific terms on the leaves [120]. However,
the majority of previous methods disregard this intrinsic hierarchical structure by
assuming that the relationships between functions are independent. Recently, sev-
eral methods have been proposed in order to take into account the interdependent
relationships between functional terms in the hierarchical structure. King et al. [121]
predicted gene functions using decision trees and Bayesian networks while taking ad-
vantage of the annotation dependency between different branches of the GO hierarchy.
Notably, when they trained and tested the association of functional terms with genes,
they excluded the information from any ancestors and descendants of the terms in
question. This ensures a fair cross validation in which prediction does not benefit
from the GO annotation rule: if one gene is annotated by a term, then that gene is
automatically annotated by all the ancestors of that term. Barutcuoglu et al. [122]
and Valentini [123] proposed a hierarchical Bayesian framework and a True Path
Rule, respectively, to perform ensemble learning of the classification results yielded
by multiple Support Vector Machines (SVMs). They demonstrated that the accu-
racy of protein function prediction can be significantly improved by integrating the
functional hierarchy [124]. Tao et al. [125] and Pandey et al. [126] utilized Lin’s sim-
ilarity [127] to flatten the functional hierarchy, and then predicted protein functions
using a k-Nearest Neighbor (k -NN) method. Sokolov and Ben-Hur [128] directly mod-
eled the hierarchical structure of functional ontology using structured SVM [129], and
showed that their method outperformed k -NN and other binary classifiers without
taking the hierarchy into account. Recently, Yu et al. [130] combined Lin’s similarity
of protein functional profiles with an ontological hierarchy using downward random
walks with restarts, so as to improve the TMC model [118], which can predict func-
tions of a protein that are not in its neighborhood, but are present in the hierarchy.
Wang et al. proposed clusDCA [131] for protein function prediction by integrating
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protein networks and a functional hierarchy, using PageRank for network smoothing
and low-rank matrix approximation to de-noise the network data.
In this study, we propose two methods that directly diffusing information on
the functional hierarchy other than a flat functional similarity constructed by Lin’s
method [127]. The first method, which we call BirgRank, constructs a Bi-relational
graph model with a protein-protein functional association network as one layer and an
unflattened ontological hierarchy as a second layer, and then directly applies PageR-
ank to diffuse annotation information across the two-layer network. The second
method, which we call AptRank, employs an adaptive version of PageRank that re-
places the standard PageRank parameters with values dynamically chosen to better
fit the training data. The main differences between our methods and other diffusion-
based methods are (1) we do not require any negative labeled samples since our
method is not a traditional classification model; (2) we take full advantage of the func-
tional hierarchy as a two-way directed graph, and do not use Lin’s similarity [127], or
any kernel trick, to flatten the hierarchy; and (3) we avoid using the annotation of a
particular term to predict the annotation of its parental terms, we train and test our
methods using the direct annotations only (see Figure 2.3(B) and (C)), which guar-
antees that the functional terms to be tested for each protein are mutually neither
ancestors nor descendants in the GO hierarchy.
To avoid the inflated accuracies of network-based methods in protein function
prediction noted by Gillis and Pavlidis [132–135], we conduct a large and strict evalu-
ation of our methods against the other state-of-the-art methods. In addition to three
small benchmark datasets, we use an up-to-date protein interaction network dataset
and exclude the functional annotations inferred from protein interactions (evidence
code: IPI). Rather than two-fold [116], three-fold [109, 131] or five-fold [118] cross
validation, we design three different validations: missing function prediction, de novo
function prediction, and a hybrid of the two strategies, namely guided function pre-
diction. For each of the three types of validation, we perform the validation method
using 20% or 10% of the data in training. To overcome the drawback of using Area
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Under the ROC curve (AUROC) as a criterion in evaluating performance on imbal-
anced data with a small number of positive samples, we also utilize Mean Average
Precision (MAP) which focuses on the ranking of positive samples only, and is widely
used in the field of information retrieval.
2.2 Methods
2.2.1 Problem Statement
This study is motivated by the fact that there are still many proteins whose func-
tions are poorly characterized. To examine the extent to which each protein has
been experimentally annotated, we downloaded three benchmark datasets of yeast,
fly and human proteins maintained by GeneMANIA-SW since 2010 from their website
http://morrislab.med.utoronto.ca/~sara/SW/, and also the human Gene Ontol-
ogy Annotation (GOA) data [136] in March 2015. For the human GOA data, we
only consider the annotations in the Biological Process (BP) category, regardless of
Molecular Function (MF) and Cellular Component (CC) terms. Also, we only use
annotations with experimental evidence codes, within which we remove the terms in-
ferred by physical interaction (evidence code: IPI). All of these four datasets will be
used for evaluation later in this study. We illustrate the proportion of the number of
functional annotations of each protein in Figure 2.1. We can see that there are a large
number of proteins with fewer than 3 functional annotations. This is primarily due to
bias in biological research interests and the difficulty of experimentally determining
protein functions.
The aim of this study is to predict protein functions given a protein-protein associ-
ation network and a hierarchically structured set of functional terms. The hypothesis
is that associated proteins in the protein network are likely to share similar func-
tions. Here, we define a protein-protein association network as pairwise quantitative
relationships of proteins. This network either can be sparse and binary, e.g., a protein-
28
Fig. 2.1. Distribution of Annotated Functions of Proteins. (A) yeast,
(B) human collected in 2010, (C) fly and (D) human collected in
2015. The yeast, human-2010, and fly datasets are collected from and
maintained by the GeneMANIA developers.
protein physical interaction network, or weighted and dense, e.g., a pairwise similarity
of protein sequences.
2.2.2 Preliminaries of Personalized PageRank
PageRank is a well-studied model in network analysis that simulates how infor-
mation diffuses across a network [115]. It is also called Random Walk with Restart
(RWR) in other literature [137]. We will use PageRank to diffuse annotation infor-
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mation from well-annotated proteins through a functional association network to less
well-annotated proteins. In particular, we use a “personalized” variation of PageR-
ank [138], which models the flow of information from a small number of specific
objects, called source nodes (in our case, a single protein) to the remainder of a net-
work. And we use this model to quantify which functions are most relevant to a
source protein.
Intuitively, personalized PageRank operates on a network of interconnected nodes
by placing a quantity of “dye” at a source node of interest, then letting the dye
diffuse across the edges of the network, decaying as it spreads. Once the diffusion
process decays to zero, the network regions where the largest amount of dye has
concentrated are then the most important regions to the source node. See Figure 2.2
for a visualization of the dye diffusing from a source node.
Mathematically, on a network with n objects, the network is modeled by an ad-
jacency matrix A ∈ Rn×n such that Aij is 1 if node j has an edge to node i, and is
0 otherwise. To model the diffusion process beginning with “dye” at a source node,
we use a vector v ∈ Rn×1 that is all 0s except for a 1 in the entry corresponding to
the source node. This vector v is called the personalization vector. Let x ∈ Rn×1
be a vector representing the amount of dye at each node in the network at some
point during the diffusion process. We then model the diffusion of the dye across the
graph by multiplying x by a column-stochastic version of A; this represents the dye
on node j being distributed in equal parts to each neighbor i of node j. We denote
the column-stochastic version of any nonnegative matrix M as M ; this is computed
by dividing each column of the matrix M by the sum of the entries in that column.
Finally, the decay of the diffusion process is controlled by the so-called PageRank
teleportation parameter, α ∈ (0, 1). During each stage of the diffusion, the dye that
spreads across the network decays proportionally to α, so that the amount of dye still
diffusing after k steps is αk. Then the PageRank vector x is given by the solution of
the linear system
(I − αA)x = (1− α)v. (2.1)
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Fig. 2.2. Diffusion Patterns of Personalized PageRank. Diffusion
starts from the node circled in black. The green dye diffuses from
the black circled node. Nodes where the diffusion concentrates the
most appear the darkest green; this indicates the nodes that are most
strongly connected to the black circled node. (A), (B) and (C) illus-
trate our AptRank diffusion with different step sizes. (D) displays our
BirgRank diffusion once the associated Markov chain has converged
to its stationary distribution.
Recall our intuition that the PageRank vector indicates how much of the dye flows
from the source node (i.e. the nonzero entry in the vector v) to each node in the
graph. In our context, this means that x will indicate how much of the functional
information flows from the protein of interest to each other protein in the graph.
31
In our model, we combine proteins and functions into a single network so that the
PageRank vector can indicate diffusion flow between proteins and functions.






This expression will become useful when we introduce the idea of using adaptive
coefficients in place of αk to optimize prediction quality (see Section 2.2.4). We note
that, although PageRank has an interpretation as a Markov chain, and Markov chains
must meet certain conditions to guarantee convergence to a stationary distribution,
this matrix power series (2.2) always converges for any α ∈ (0, 1) and stochastic
matrix A. Thus, the existence of the unique solution x is guaranteed regardless of
the structure of the matrix A. We emphasize this because the form of linear system
that we use differs from the traditional PageRank setting, which uses Markov chain
analysis in the proof of its convergence; in contrast, our computations do not rely on
this Markov chain analysis.
2.2.3 BirgRank: Bi-relational graph PageRank model
We denote the number of proteins by m and the number of function terms by n.
Then the three given datasets (protein-protein association network, protein-function
annotations, and function-function hierarchy) are denoted by the following matrices:
• G ∈ Rm×m, a symmetric matrix where G(i, j) denotes to which extent protein
i is associated with protein j;
• R ∈ Rm×n, a binary matrix where R(i, j) = 1 if protein i is annotated by
function j, 0 otherwise; and
• H ∈ Rn×n, a binary matrix where H(i, j) = 1 if functional term i is the child
of term j, 0 otherwise.
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We illustrate these three components in Figure 2.3(A), (B) and (C), using a small ex-
ample with 6 proteins and 7 functional terms. For simplicity, Figure 2.3(A) shows a
protein-protein binary interaction network, but it can be replaced by any protein-
protein association network. Functional terms are hierarchically structured in a
Gene Ontology (Figure 2.3(C)) like an upside down “tree”, where the terms on the
top (root) are more general and the ones in the bottom (leaves) are more specific.
The annotation rule is that if one gene/protein is annotated by one term, then this
gene/protein is automatically annotated by all the parental terms of that term in the
hierarchy. However, note that in this study we only consider training and predict-
ing the direct annotations of each protein, and do not propagate the corresponding
parental annotations using the annotation rule, as shown in Figure 2.3(B). This en-























Fig. 2.3. Visualization of Given Data in a Simple Case. (A) protein-
protein binary interaction network, (B) protein-function reference ma-
trix, (C) function-function hierarchy, (D) adjacency matrix A of a
bi-relational graph.
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Next, we construct a bi-relational graph [119] that incorporates these three datasets
into a single network (Figure 2.3(D)). To evaluate prediction performance, we split all
the annotations in R into RT , which we use for training during model construction,
and RE, which we use for evaluating predictions (see Figure 2.4). For each protein
i, we predict its functions using Equation (2.1) by setting it as the diffusion source,
i.e., by computing the diffusion using v = ei. To predict the functions of all proteins,














where the bar over the block matrix still indicates the whole matrix is normalized to
be column-stochastic. The lower block of the solution, XH , is the output matrix of
BirgRank for function prediction, and has the same dimensions as RT . To further
control the proportion of diffusion passing between the two layers of the bi-relational














whereH∗ = λH+(1−λ)HT , and λ controls the diffusion direction onH . Specifically,
λ = 0 indicates that the diffusion flows down the hierarchy, and 1 indicates flow up
the hierarchy. The parameter µ ∈ (0, 1) controls the proportion of the diffusion
flowing within G, and θ ∈ (0, 1) controls the weighted sources between the proteins
and functional annotations in the right-hand side of Equation (2.4).
2.2.4 Extension to AptRank
In the traditional model of PageRank, which we use in BirgRank, the teleporta-
tion parameter α ∈ (0, 1) can be thought of as controlling the rate of decay of the
diffusion as it spreads from the nodes in the personalization vector v to the rest of
the graph. After k steps the diffusion has decayed by a factor of αk, for k = 1, · · · ,∞
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(Equation (2.2)). There are a variety of other empirical weighting schemes [139–142],
each with slightly different theoretical properties.
In this section, we seek to replace the standard, fixed diffusion coefficients αk at
each step with an adaptive parameter, denoted by γ(k), to optimize the predictive
power of the Markov chain. To do this we repeatedly split the training set of protein
function annotations, RT , into different subsets to use in fitting and validating the
coefficients. We denote the matrix used for fitting by RF , and the matrix used in
validation by RV . These matrices have the same dimensions as RT and consist of
entries of RT , i.e., RT = RF +RV .
To determine the adaptive coefficients γ(k) so that they bias predictions toward
the training data, we proceed as follows. The AptRank method begins by computing























0 to use a one-way diffusionRF to use a two-way diffusion .
We denote AptRank using a one-way diffusion and a two-way diffusion as AptRank-1
and AptRank-2, respectively. These two variations can have significant differences in
prediction performance when the underlying networks have different sparsities.
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To compute the optimal set of coefficients γ(k) that best fits the validation set RV ,


















where vec(·) is a matrix-to-vector transformation that stacks the columns of the ma-
trix into a single column vector.
The entire AptRank framework is summarized in Algorithm 1. We perform this
fitting-validating process multiple times, each time splitting t% of entries in RT into
new matrices RF and RV by choosing entries from RT uniformly at random. Each
such iteration generates a new set of coefficients γ(k), which we store. We call these
iterations “shuffles” because in essence they consist of shuffling the entries of RT into
the two matrices RF and RV . Again, we note that the annotations in each row (for
each protein) of RF and RV do not share parental ontology terms. The number of
shuffles performed, denoted as S, is an input parameter; after the prescribed number
of shuffles is completed, we compute the average γ∗(k) of the γ(k) across all shuffles,
and use those averaged γ∗(k) to compute the final diffusion values XAptRank. This
prediction solution will be compared against the evaluation set RE (see Section 2.3).
2.2.5 Connection with Other Methods
To investigate the similarities and differences of our methods and the other four
previous methods used for evaluation, we perform a theoretical analysis and compar-
ison here, and summarize the features of each method in Table 2.1.
The linear system of BirgRank in Equation (2.3) can be expanded into(I − αG˜)XG = (1− α)IαR˜T TXG = (I − αH˜)XH , (2.8)
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Algorithm 1: AptRank
Input : G,RT ,H
∗,K,S,t
Output: XAptRank
1 for s← 1 to S do
2 [RF , RV ] ← splitR(RT ,t)
// Choose t% of nonzero entries in RT uniformly at random and split to RF , and derive
RV = RT −RF .
3 Initialize X(0) using Equation (2.6)
4 for k ← 1 to K do
5 Compute X(k) using Equation (2.5)
6 A[:, k]← vec(X(k)H )
7 end
8 [QA,RA] ← qr(A) // QR decomposition










k = 1, γ
(s)
k ≥ 0
// Equivalently as Equation (2.7).
11 end
12 γ∗ ← median(γ(s))













14 Output XAptRank ←X∗H for use in prediction.
where G˜, R˜T , and H˜ = H denote the submatrices of the column-stochastic matrix
in Equation (2.3). By solving Equations (2.8) for XH , we get
XH = α(1− α)(I − αH)−1R˜T T (I − αG˜)−1. (2.9)
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In contrast, ProteinRank [116] uses only the protein-protein association network
G as a one-layer network model — and does not directly take into consideration the
functional hierarchy H — and then computes PageRank using RT as the personal-
ization vectors (matrix). ProteinRank constructs a regression model and solves the
linear system
XProteinRank = (1− α)(I − αG)−1RT , (2.10)
which can cause poor prediction quality due to the assumption of independence be-
tween functions (see Section 2.3). Our method BirgRank is closely related to Protein-
Rank: if we plug H = I into Equation (2.9), then the resulting BirgRank solution
differs from the ProteinRank solution (Equation (2.10)) only by a scalar coefficient
and a slightly different normalization of G.
Similar to ProteinRank, GeneMANIA [109] models protein function prediction as
a multiclass-multilabel classification problem by integrating multiple heterogeneous
network datasets and then using the Label Propagation algorithm [117] as
XGeneMANIA = (I −L)−1R∗T , (2.11)
where L = D−W is the Laplacian matrix, W is a weighted sum of multiple kernel
matrices from heterogeneous network data sets, and D is a diagonal matrix with
Dii =
∑




introducing negative samples in which R∗i,j = −1 if protein i is known not to have
function j. The developers of GeneMANIA further accelerated their algorithm by
introducing Simultaneous Weights (hereafter GeneMANIA-SW) [143].
Yu et al. proposed the Transductive Multilabel Classifier (TMC) [118] by di-
rectly applying a Bi-relational graph model used in image annotation [119] to protein
function prediction, without consideration of the functional hierarchy. Instead, they
use the cosine similarity of functional annotations to construct a function-function
similarity matrix to replace H . The key difference between TMC and BirgRank is
that TMC allows information to diffuse from functional terms to proteins, but not
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proteins to functional terms, as in BirgRank. Mathematically, the transition matrix





where the matrix W F is the degree-weighted function-function cosine similarity, i.e.,
cos(RTT ,RT ), WG is a degree-weighed graph kernel of protein-protein association
network, and WR is a normalized function profile derived from RT . The developers
of TMC suggest further flattening the functional hierarchy by using a random walk
with restart approach [130]. But this method, called dRW, does not use a bi-relational
graph model, and was tested only using a very small data set [130].
Wang et al. proposed clusDCA [131] by extending their original Diffusion Com-
ponent Analysis (DCA) method [144]. The clusDCA algorithm first uses PageRank
to smooth both of the graphs, denoted as G and H in this study. Next, it computes
Singular Value Decomposition (SVD) for the two smoothed matrices for low-rank
matrix approximations. Finally, it attempts to find the optimal projection between
the two low-rank matrices.
2.3 Results
2.3.1 Experimental Setup
We present a comprehensive evaluation of the six methods using the three bench-
mark datasets from yeast, human and fly that can be downloaded from the GeneMANIA-
SW website. All three datasets were collected by the developers of GeneMANIA in
2010. We collected one more dataset for human proteins from public databases in
March 2015 in order to test all the methods using up-to-date data with a larger
size than those collected in 2010 (see Table 2.2). In this human dataset, denoted
as human-2015, the network G was downloaded from BioGRID [145], and the an-
notations R and the hierarchy H from the Gene Ontology Consortium [136]. The
number of direct GO (Table 2.2, 3rd column) indicates the number of annotations of
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individual proteins directly downloaded from the Gene Ontology Annotation (GOA)
database. This does not reflect the implied inclusion of parental terms (see the total
number of terms in Table 2.2, 4th column for comparison). The multiple kernels
(Table 2.2, 5th column) from heterogeneous molecular data were directly downloaded
from the GeneMANIA-SW website, and combined into a single network (i.e., G) with
the weights provided in the datasets.
To evaluate the quality of each method in protein function prediction, we con-
ducted cross validation using three different strategies to split the given functional
annotation data R into RT used for training and RE used for evaluation (see Sec-
tion 2.3.2). The three strategies are:
1. missing function prediction
2. de novo function prediction
3. guided function prediction.
All three validation strategies ensure that the matrices R, RT and RE have the same
dimensions, and R = RT +RE. To measure the prediction quality of each method,
we use two evaluation metrics: AUROC (Area Under the Receiver Operating Char-
acteristic curve) which is widely used in protein function prediction, and MAP (Mean
Average Precision) which is widely used in information retrieval (Figure 2.4). The
key advantage of MAP is that MAP does not take true negatives into account, and
is thus a more informative metric than AUROC when negative samples outnumber
positive samples. This is true in our case since in the human-2015 dataset, for exam-
ple, we attempt to predict 45 functions on average from 11, 519 possible annotations
(feature space, see Table 2.2).
We determined parameter settings as follows. For the four methods other than
our BirgRank and AptRank, we mostly used the default settings specified in the cor-
responding literature. We only tuned the reduced dimensionality d in clusDCA to
be 500, rather than the parameter setting 2, 500 specified by the authors [131], since










Fig. 2.4. Validation Strategy of Missing Function Prediction. Split
the given annotations R by putting 50% into the training set RT and
50% into the evaluation setRE. Then compare the predictions against
RE and evaluate the performance of each method using AUROC and
MAP.
that clusDCA is the most time-consuming method as shown in Table 2.4, and a large
d value dramatically increases running time. For the parameters in BirgRank, we set
λ = 0.5 in determining H∗, to allow equal diffusion upward and downward the hier-
archy. For the other three parameters α, θ, and µ in BirgRank (See Equation (2.4)),
we observed that different settings of these three parameters did not yield significant
differences in performance, and found that a value of 0.5 empirically achieved good
results. For the parameters in AptRank, we set the total iteration number K to be
8, the splitting parameter t to be 50%, and the number of shuffles S to be 5. These
setting may vary depending on the validation strategies and the data sizes, which we
discuss in Section 2.3.2.
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2.3.2 Comparison of Prediction Performances
Missing Function Prediction
We first conducted a numerical experiment to evaluate the ability of the six meth-
ods in predicting missing protein functions as follows. We uniformly select a certain
percentage of non-zero entries in R at random, move them to a matrix RT for train-
ing, and let RE = R −RT be the evaluation set. Figure 2.4 illustrates how to split
matrix R with 14 entries into RT and RE when the splitting percentage is specified
as 50%. We carried out this random sampling with replacement 5 times for each
specified splitting percentage. This is not a circular cross validation since it does not
guarantee that each functional annotation is tested once and only once. This strategy
aims to test whether the methods can restore incomplete functional annotations for
each protein and is unbiased with respect to how many annotations each protein has.
We start with 10% split for training and increase by increments of 10% up to 80%
(Figure 2.5). Generally, the resulting AUROCs and MAPs of the six methods show
that both BirgRank and AptRank outperform the other four previous methods in all
8 groups of experiments with different amounts of training data. In the 10% group of
human-2010 and fly datasets, clusDCA slightly outperforms our methods in AUROC,
but its MAP is lower than those of our methods (Figure 2.5 (C) and (E)). When more
data are given for training, our methods outperform the other four methods in terms
of MAP with approximately 2- to 3-fold improvement.
To investigate the effect of the GO functional hierarchy in prediction, we com-
pare the performance of non-hierarchy-integrated methods (GeneMANIA-SW, TMC
and ProteinRank) with hierarchy-integrated methods (clusDCA, BirgRank and Ap-
tRank). We find that the integration of the functional hierarchy clearly improves the
prediction accuracy (Figure 2.5). Furthermore, our methods, for the most part, per-
form better than clusDCA, which suggests that using a bi-relational graph framework
(Figure2.3) to integrate the hierarchy is better than seeking for projection between
the protein network and the functional hierarchy.
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GeneMANIA-SW TMC ProteinRank clusDCA BirGRank AptRank-1 AptRank-2
Fig. 2.5. Missing Function Prediction. The x -axis represents the
percentages of data used in training. The error mark on top of each
bar indicates the standard deviation of AUROCs or MAPs over 5
repetitions of each experiment.
Comparing the performances of BirgRank and AptRank, we find that the perfor-
mance of the algorithms differs as the network sparsity varies (Figure 2.5 (B), (D),
(F) vs. (H)). The three benchmark datasets are smaller and denser than Human-2015
dataset due to the integration of multiple kernels (Table 2.2). We can see that Ap-
tRank with a two-way diffusion performs better on the dense network, while BirgRank
is better on the sparse network. This could be because a dense network restricts net-
work diffusion within a local region of the source node, and two-way diffusion forms a
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feedback loop that enhances the contributions of the annotations within local regions.
However, the two-way diffusion spreads out of this local region in a sparse network
and provides irrelevant feedback to the source node.
In addition, we find that GeneMANIA-SW and ProteinRank achieve similar per-
formance in both AUROC and MAP. The key difference between these two models is
that GeneMANIA-SW requires negative samples in its classification framework. This
demonstrates that negative samples have a very limited contribution to the perfor-
mance of GeneMANIA-SW on these datasets. This could be in part because it can
be difficult to confirm that a protein does not have a function.
Lastly, we find that BirgRank outperforms TMC. Theoretically, the models of
TMC and BirgRank are quite similar, differing mainly in how the two methods direct
the diffusion between the two network layers, G and H . BirgRank diffuses informa-
tion from G to H , while TMC does the reverse. Our results support the idea that
diffusion from proteins to functional terms is the more useful direction in the context
of protein function prediction.
De novo Function Prediction
To investigate whether the six methods can accurately predict the functions of
one protein without any annotation for training, we design a de novo circular cross
validation as follows. Uniformly partition a certain percentage, denoted as c, of
proteins into b groups at random. Letting [v] denote the nearest-integer operation,
we can calculate
b =
[1/c] if 0 < c ≤ 0.5[1/(1− c)] if 0.5 < c ≤ 1 .
In practice, we set c as 20%, 50% and 80% as shown in the x-axis of Figure 2.6.
When c = 80%, it is equivalent to a conventional five-fold cross validation with 80%
of proteins as the training set and the complementary 20% as the evaluation set. On
the contrary, c = 20% means we only use 20% of proteins for training and evaluate the
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prediction performance by the complementary 80%. Lastly, c = 50% is equivalent to
a two-fold cross validation. Normally, three-fold cross validation (c = 66.7%) is used
in the four reference methods. Here, our cross validation design is aimed to explore









































































GeneMANIA-SW TMC ProteinRank clusDCA BirGRank AptRank-1 AptRank-2
Fig. 2.6. De novo Function Prediction. The x -axis represents the
percentages of data used in training. The error mark on top of each
bar indicates the standard deviation of AUROCs or MAPs over 3
repetitions of each experiment.
As shown in Figure 2.6, our methods generally perform no worse than the four
reference methods. Interestingly, GeneMANIA has nearly the same performance as
ProteinRank in both AUROC and MAP metrics, which occurs in our missing function
prediction experiment as well (Figure 2.5). Furthermore, they both perform better
than the other two reference methods, TMC and clusDCA. Our methods perform
slightly better than GeneMANIA and ProteinRank in AUROC, but do slightly worse
in MAP. This leads us to conclude that (1) a classification model that includes neg-
ative samples (GeneMANIA) is little different from a diffusion model (ProteinRank)
in de novo function prediction; and (2) integrating the GO hierarchy (BirgRank and
45
AptRank) cannot significantly improve the accuracy in function prediction for newly
found proteins without known functional information.
Guided Function Prediction
To examine the extent to which our methods benefit from limited known an-
notations of tested proteins, we devise a validation strategy called guided function
prediction which is a hybrid of the missing function prediction (Section 2.3.2) and the
de novo prediction (Section 2.3.2) strategies. In this validation, the strategy of par-
titioning training and evaluation sets is identical to that used in de novo prediction
except that it gives one functional annotation as guidance for each evaluated protein
that has more than one annotation. The proteins in the evaluation set with only one









































































GeneMANIA-SW TMC ProteinRank clusDCA BirGRank AptRank-1 AptRank-2
Fig. 2.7. Guided Function Prediction. The x -axis represents the per-
centages of data used in training. The error mark on top of each bar
indicates the standard deviation of AUROCs or MAPs over 3 repeti-
tions of each experiment.
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We can see in Figure 2.7 that in the evaluations using the three benchmark datasets
with dense network data, our methods, especially AptRank-2, can take full advantages
of the single given annotation to improve prediction performance by approximately
2-fold in AUROC and 3-fold in MAP, compared to the other four methods. In the
sparse network data (Human-2015), we find that the given annotations worsen the
performances of all the methods (Figure 2.6 (G,H) vs. Figure 2.7 (G,H)). We con-
clude that sparse network datasets may cause underfitting of our model training, and
reducing the model complexity can alleviate this problem, e.g., setting a small α in
BirgRank or a small K in AptRank. On the contrary, we also find that in some
experiments, the more data we provide for training, the worse the testing accuracy
is (e.g., AptRank-2 in Figure 2.6(F)). In these cases, Verleyen et al. proposed using
sampling of the training data to overcome this overfitting [146].
Finally, all three validations show that AUROC is always higher than MAP in the
evaluation of the same prediction result. This suggests that MAP is a better metric
when the number of negative samples is much larger than the number of positive
samples, as is the case in protein function prediction.
2.3.3 Analysis of Adaptive Coefficients
The adaptive coefficients of AptRank (γ) are the unique feature that differs from
traditional PageRank. To investigate their behaviors in prediction, we list the medians
of γ over the different shuffles in the prediction of yeast and human-2015 datasets in
Table 2.3. We can see that there are three main features of γ’s behaviors,
(1) γ(1) is always zero, since the information diffusing within G, from proteins at the
first step, has not yet reached the hierarchy;
(2) as shown in the yeast dataset, the distribution of γ is not uniform, but concen-
trates on specific terms of Markov chains, which demonstrates that AptRank can
adaptively select the most predictive terms rather than weighting all terms with
power-decays like traditional PageRank; and
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(3) in comparison of γ in yeast and human-2015 datasets, we find that AptRank
mostly selects the 2nd term in the human-2015 dataset, but a few more terms
in the yeast dataset, which is due to the different network densities of the two
datasets. The yeast dataset is smaller but denser, since it integrates 44 different
kernels into G; the human-2015 dataset is larger but sparser, and all the entries
in the raw human-2015 dataset are binary. This implies that for a sparse dataset,
our AptRank might be equivalent to neighbor-voting methods.
2.3.4 Comparison of Runtimes
The average computational time of the six methods compared in this study are
shown in Figure 2.4. In this comparison, the computational time is recorded for the
prediction using the largest dataset, human-2015. We can clearly see AptRank re-
quires the third longest computational time, likely because it involves many dense
matrix operations. The SVD computations required in clusDCA are likely responsi-
ble for clusDCA having the longest running time. Without a parallel implementation
of SVD, clusDCA might be impractical unless we sacrifice prediction accuracy by
using a small d value. GeneMANIA-SW is the second most computationally expan-
sive method, since it computes the prediction scores function by function. This is
extremely expensive when the number of functions is large, even though we only used
direct GO terms in GeneMANIA-SW. BirgRank and TMC both use bi-relational
graphs, and take only several minutes to solve the PageRank linear system. Protein-
Rank has the most simple model, and it takes the shortest time, since it needs only to
solve a PageRank linear system with approximately half the dimension of the systems
involved in BirgRank and TMC.
2.4 Conclusion
In this paper we present two network-diffusion-based methods for protein function
prediction. Our first method, BirgRank, uses PageRank on a bi-relational graph
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model that incorporates protein-protein and function-function networks. Our second
method, AptRank, introduces an adaptive mechanism to the PageRank framework
that computes an optimal set of weights for the first several steps of diffusion so as
to maximize recovery of a subset of known function annotations. We show that both
methods outperform the four existing state-of-the-art methods in almost all cases,
and in particular, outperform those methods that do not incorporate information
about the functional hierarchy. Our results also suggest that diffusion-based methods
are still among the most competitive in network-based protein function predictions,
compared to classification-based and decomposition-based methods.
Furthermore, our methods provide a theoretical framework in data integration,
which may benefit multi-omics studies in complex diseases, or multi-species metabolic
network modeling in microbiome studies. From a general view outside bioinformat-
ics, our methods can be used to develop multi-class recommendation systems in social
media with inter-dependent labels. For example, the protein-protein association net-
work in this study can be viewed as similar to the professional social network between
LinkedIn users, and the functional hierarchy can be seen as generalizing to an indi-
vidual’s skill set. Those skill sets are typically inter-dependent. For instance, a user





































































































































































































































































Yeast 3904 1188 1695 44
Human-2010 13281 1952 2919 8
Fly 13562 2195 2919 38
Human-2015 14515 11519 27106 1
Table 2.3






1st 2nd 3rd 4th 5th 6th 7th 8th
Yeast
10% 0 0 0 0 0 0 0.08 0.92
20% 0 0.11 0 0 0 0 0.23 0.66
30% 0 0.34 0 0.08 0 0 0.58 0
40% 0 0 0 0 0 0 1 0
50% 0 0 0 0 0.84 0 0.16 0
60% 0 0 0 0 1 0 0 0
70% 0 0 0.09 0 0.91 0 0 0
80% 0 0 0.64 0 0.36 0 0 0
Human
2015
10% 0 0.20 0 0 0 0 0.31 0.49
20% 0 0.65 0 0 0 0 0.11 0.24
30% 0 1 0 0 0 0 0 0
40% 0 1 0 0 0 0 0 0
50% 0 1 0 0 0 0 0 0
60% 0 1 0 0 0 0 0 0
70% 0 1 0 0 0 0 0 0
80% 0 1 0 0 0 0 0 0
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Table 2.4
Runtimes of the Six Methods in Minutes (Human-2015 Dataset)*
Methods
Training Data Proportion
10% 20% 40% 50% 70% 80%
GM-SW 252.52 214.47 232.02 231.65 225.54 234.56
TMC 6.71 7.10 7.52 7.58 7.37 7.12
ProteinRank 0.85 0.87 0.87 0.87 0.88 0.88
clusDCA 1054 1019 1072 1061 1025 1050
BirgRank 9.42 9.46 9.46 9.45 9.42 9.49
AptRank-1 51.79 53.48 55.82 55.28 57.85 58.69
*The runtimes of 30% and 60% is not shown due to space limit. The AptRank-1 uses 12-core
parallel computing for matrix multiplication.
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3. NETWORK PARTITIONING: FUNCTIONAL
MODULE DETECTION
Real-world networks are usually too large to be investigated in details. For ex-
ample, given a global protein-protein interaction network with thousands of proteins,
molecular biologists may get lost in this big data set. Network scientists overcome
this challenge by breaking down large networks into several small subnetworks accord-
ing to some intrinsic patterns. In biological networks, computational biologists often
partition a molecular network into several functional modules within which molecules
are densely connected and also share similar biological functions.
In this Chapter, we extend our AptRank model described in Chapter 2 for bio-
logical network partitioning. In particular, we develop a computational tool, namely
BioSweeper, for joint clustering of multilayer biological networks. BioSweeper first
adopts localized PageRank to diffuse information from a set of seed nodes, which
generates, for each seed node, a ranking list of nodes in the network representing
the proximity to the seed nodes. Next, BioSweeper detects a network cluster with
the minimal conductance by sweeping over all cuts induced by the ranking list. We
test the performance of BioSweeper against two state-of-the-art methods, MCL and
ClusterONE, in protein complex detection using a benchmark dataset from the MIPS
database. Experimental results show that, given an appropriate seed set, BioSweeper
outperforms the other methods in terms of identifying gold-standard protein com-
plexes. We then apply BioSweeper to detecting long-range regulatory modules in
which genes are strongly co-expressed and their genomic regions have highly frequent
contacts.
The main contributions of BioSweeper are the capabilities of (1) detecting over-
lapping clusters; (2) integrating heterogeneous datasets for multimodal cluster iden-
tification; and (3) tuning cluster sizes between small and large.
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3.1 Background
Most of biological networks are too large to be investigated at molecular lev-
els. And those networks are usually organized in hierarchical and modular struc-
tures [88,89]. Thus, partitioning those networks into small subnetworks using compu-
tational methods becomes a daunting challenge in systems biology [147]. Many com-
putational methods have been developed to automatically identify functional modules
in biological networks, including Markov CLuster (MCL, [112]), Molecular COmplex
DEtection (MCODE, [113]), Restricted Neighborhood Search Clustering algorithm
(RNSC, [148]), CFinder [149, 150], Affinity Propagation [151], Repeated Random
Walks (RRW, [152]), linkcomm [153,154], ClusterONE [155], and so on. Wiwie et al.
conducted a comprehensive comparison of multiple clustering algorithms using many
benchmark data sets, but could not find a universal best performer across all the data
sets [156].
The original definition of biological network partitioning is similar to that of com-
munity detection in social network analysis, i.e., to seek for subnetworks with dense
connections inside and loose connections to the outside, given the network connec-
tions only. The subnetworks detected following this definition may be insufficiently
meaningful in biology, in the sense that a densely connected subnetwork is likely to be
a protein complex (e.g., proteasome), but rarely to be a signaling cascade with linear
structure (e.g., mitogen-activated protein kinase (MAPK) cascade). And therefore,
only can combining functional annotations with network connectivity detect more
biologically meaningful functional modules including protein complexes and signaling
cascades. Lubovac et al. developed SWEMODE (Semantic WEights for MODule
Elucidation, [157]) to detect functional modules from protein interactome using a
weighted version of clustering coefficient on the weighted protein interactome with
Lin’s semantic similarity [127] of protein function profiles. Cho et al. presented a
flow-based modularization algorithm on a weighted protein interactome combined
with functional semantic similarity to detect functional modules [158]. Marcus Dit-
54
trich and his colleagues extended their integer-linear programming model for protein
functional module detection, LiSA [159], by integrating semantic similarity of protein
functional profiles [160]. These integrative methods let the protein interactome con-
vey rich functional information, and have demonstrated that integrating functional
information to protein interactome directly yields functional enriched modules after
the network partitioning.
Most network partitioning algorithms produce disjoint subnetworks. However,
there are many multi-functional proteins playing different roles in distinct biological
processes. Those critical nodes [161] usually have more than one isoform, and can
be highly regulated either positively or negatively to generate signaling divergence in
downstream regulation. To this end, computational biologists attempt to partition
a network by allowing the subnetworks having overlapping regions, so that those
multi-functional proteins can be partitioned into more than one functional module.
Palla et al. presented CFinder [149, 150] to detect functional modules by seeking for
overlapping k-clique communities, i.e., complete subgraphs of size k. They claimed
that overlapping communities are prevalent in a variety of real-world networks, and
traditional clustering strategies such as divisive and agglomerative methods cannot
identify such overlapping structures. Ahn et al. proposed a novel concept, link
community, to identify overlapping communities using hierarchical clustering in a
line graph where each node represents an edge in the original graph, and two nodes
are connected if the corresponding two edges share a common node in the original
graph [153]. If two edges are connected to one node but belong to two different link
communities, then that node belongs to the two communities as well. Nepusz et al.
presented ClusterONE, a fast method to search for protein complexes on protein-
protein interaction networks using a greedy strategy to grow a seed module in order
to maximize a cohesiveness score [155]. The score is defined as the weights of within-
module edges over the sum of within-module edges, boundary edges, and a penalty
term. They claimed that ClusterONE can naturally adapt to weighted graphs, and
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that the accuracy of identifying protein complexes is higher than those of the other
clustering methods, such as MCL, MCODE, RNSC, Affinity Propagation, and RRW.
Network data are sometimes heterogeneous, in which nodes present more than
one type of objects. Those heterogeneous data are usually described as a multilayer
network with the same of type of objects in the same layer. How to perform network
partition in those multilayer networks is still elusive. Mucha et al. modified the
traditional modularity score [91] to obtain a multislice generalization of modularity for
time-dependent community detection in social networks [162]. In terms of biological
network, Xianghong Jasmine Zhou and her colleagues proposed a series of methods
[163, 164] to identify gene regulatory modules in a multilayer network comprising
multiple types of genomic data: copy number variation, DNA methylation, mRNA
expression, and microRNA expression. Wang et al. constructed a similarity network
of cancer patients using multiple types of genomic data, and then partitioned the
network using similarity network fusion to divide the patients into different cancer
subtypes [165].
In this study, we extend our AptRank (described in Chapter 2) to partition mul-
tilayer molecular networks into overlapping functional modules. In particular, our
method, namely BioSweeper, identifies network modules using the following three
stages: (1) diffuse information throughout the two-layer network from a set of seed
nodes using a localized PageRank algorithm [166]; (2) for each diffusion from a seed
node, sort each node in the network in descending order of information intensity, and
then sweep over the ranking list of the nodes to find a partition with the minimal
conductance value; and (3) merge two groups of nodes together if their overlapping
region is above a threshold. For evaluation, we first use BioSweeper to partition a
protein-protein interaction network interconnected with the Gene Ontology hierarchi-
cal structure as the second layer. Unlike the existing methods, MCL and ClusterONE,
BioSweeper automatically detects functionally enriched modules by partitioning the
two-layer network. We also test BioSweeper by partitioning a gene co-expression net-
work interconnected with a Hi-C contact network between genomic regions, which can
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identify long-range regulatory modules in which the genes are strongly co-expressed
and their genomic regions have strong Hi-C contacts.
3.2 Methods
Before describing the methodology of BioSweeper, we first describe the notations
for the primary data elements and the problem we attempt to solve. We use the
same notations in AptRank (see Chapter 2) to describe a two-layer network with two
distinct types of nodes at each layer. The adjacency matrix of the first-layer network
with m type-1 nodes is denoted as G ∈ Rm×m. The second layer network with n
type-2 nodes is denoted as H ∈ Rn×n. And the interconnections between type-1 and
type-2 nodes are indicated as a matrix R ∈ Rm×n. The task is to partition m + n
nodes in this two-layer network into ` overlapping modules such that each module
has at least one type-1 node and one type-2 node. In this Chapter, the terms module,
cluster, and community have the same meaning, and hence are used interchangeably.
3.2.1 Localized PageRank Diffusion





















where A denotes column-wise normalization of matrix A. The parameters σ and τ ,
ranging from 0 to 1, control the proportion of information diffusion between the two
layers of the network. In this diffusion system, the information diffuses from each
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node, as denoted by Im in the right-hand term, through the connectivity within G,
or the connectivity of RT between the two layers, to the second layer H , and then
goes back to G through R. In AptRank for protein function prediction, the solution
to functional prediction is XH , whereas for partitioning of this two-layer network, we
need to use the whole solution X ∈ R(m+n)×m. The i-th column of X, denoted as xi,
represents the information intensity after the Personalized PageRank starting from a
type-1 node i.
In order to obtain a good partition, we need to prevent the information diffusion
from going too far away from the source node. There are many techniques to restrict
information diffusion by modifying the traditional PageRank. One of them is to use
heat kernel in place of the fixed-decay parameter α used in the traditional PageRank
[141,167]. Compared to the fixed-decay coefficient αk at k-th step diffusion, the heat
kernel coefficient tk/k! decays much more quickly, and strongly weights early steps of
diffusion. Another method to localize PageRank is to obtain a sparse and approximate
solution x to Equation 3.2 such that ‖x−x‖1 ≤ . This sparse solution with localized
behaviors in diffusion proved to be able to provide a good network partition [166,168].
We utilize the algorithm described in ref. [166] to obtain a sparse solution to the
Equation 3.2. Generally, this algorithm adopts Gauss-Southwell iteration to solve a
PageRank linear system (I − αP )x = (1− α)es where es is an all-zero vector except
the s-th entry as 1 that represents the seed node. First, initialize the solution x(0) = 0
and the residual r(0) = (1− α)es. Denote the approximate solution as x(k) at k-step
iteration, and the corresponding residual as r(k). The Gauss-Southwell iteration then
updates the entry j of x(k) that corresponds to the largest entry j of r(k), denoted as
r = r
(k)
j , as follow:
x(k+1) = x(k) + rej
r(k+1) = r(k) − r(I − αP )ej.
(3.3)
Next we describe how to use these sparse PageRank vectors to obtain optimal
partitions of the two-layer network.
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3.2.2 Finding Min-conductance Partition
Given a traditional Personalized PageRank vector, Andersen et al. proposed a
method to identify a network partition with small conductance around the starting
node [169]. The details of this procedure is visualized in Figure 3.1 using a small
network with 9 nodes and 14 edges. We adopt this method to identify optimal
modules given our localized PageRank vectors xi, i = 1, 2, · · · ,m from a two-layer
network diffusion. To define the conductance, the quality score of a module, let us
define several preliminary concepts first. Denote the whole set of nodes in a graph
as V . For two arbitrary modules Cp, Cq ⊆ V , define links(Cp, Cq) as the sum of edge
weights between the node sets Cp and Cq. The cut of a module Ci is defined as the
sum of edge weights between the nodes in Ci and its complement V \ Ci as follows,
cut(Ci) = links(Ci,V \ Ci). (3.4)
Then let us formally define the conductance of a module Ci as
cond(Ci) = cut(Ci)
min (links (Ci,V) , links (V \ Ci,V)) , (3.5)
where links(Ci,V) and links (V \ Ci,V) represent the number of edges incident on
set Ci and V \ Ci, respectively. In implementation, we in fact compute links(Ci,V)
for any set Ci as the sum of the degrees of the nodes in that set.
Taken together, the Andersen-Chung-Lang procedure [169] is to first sort the nodes
in descending order of the PageRank vector normalized by the degree, xi/deg(i), and
then to calculate the conductance of each prefix set of nodes to obtain the set of
nodes with lowest conductance as the partitioned module. Take a small network in
Figure 3.1 as example. The PageRank diffusion starts from node-1, and finally reaches
a stationary phase with the intensity distribution denoted as x. Then the stationary
intensity x is normalized by the degree of each node, and is sorted in descending
order. We compute the conductance of each prefix set following the ranking list of
nodes: {1}, {1, 2}, {1, 2, 3}, · · · , {1, 2, 3, · · · , 8, 9}. The conductance values of these 9
sets are shown in the bottom-right panel of Figure 3.1. We can see that the prefix set
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{1, 2, 3, 4, 5, 6} has the minimal conductance value, which means this set of nodes is
the best partition for the diffusion from node-1. We search for the optimal partition











































Fig. 3.1. Module Detection by Sweeping Over PageRank Vector. Left
panel: a small network with 9 nodes and 14 edges. The gray dashed
circle indicates the best partition. Top-right panel: x, the stationary
distribution of PageRank diffusion from node-1, is normalized by the
degree of each node, and is sorted in a descending order. Bottom-right
panel: the conductance value of each prefix set.
3.2.3 Post-processing
Given a set of lowest-conductance modules obtained by BioSweeper seeded on
each node in the first layer network G, we merge similar modules by thresholding the
following pairwise module similarity score based on the Jaccard index,
J(Ci, Cj) = |Ci ∩ Cj||Ci ∪ Cj| . (3.6)
If J(Ci, Cj) > 0.5, we merge Ci and Cj as one single module.
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3.3 Results
We test our network partitioning algorithm, BioSweeper, on two different biolog-
ical networks: a protein interactome and a gene co-expression network.
3.3.1 Partitioning Protein Interactome
We seek for protein complexes from a protein interactome of budding yeasts
using BioSweeper. The protein interactome resource is from the BioGRID [145].
The functional annotations and the hierarchy are from the Saccharomyces Genome
Database [170]. To verify whether the identified modules are truly protein com-
plexes, we collected a gold-standard protein complex set from the MIPS (Munich
Information Center for Protein Sequences, [171]). In fact, the interactome and the
gold-standard reference set were directly obtained from the supplemental materials
of ClusterONE [155].
Totally, there are 5, 640 proteins and 59, 748 interactions in the yeast protein
interactome. We collected the GO functional annotations for these proteins, and
obtained 33, 922 direct protein-function annotations between the proteins and 7, 735
GO terms. We used these datasets to construct a two-layer network with the proteins
as the nodes in the first layer and the GO terms as the nodes in the second layer.
We then partition this network into modules with proteins and GO terms together,
which automatically produces functionally enriched modules.
In the gold-standard reference set, there are 203 yeast protein complexes ranging
in size from 3 to 95 protein subunits. To evaluate our predicted protein complexes, we
adopted the evaluation metric, MMR (maximum matching ratio) used in ClusterONE
[155]. Unlike the original MMR based on an overlapping score between two clusters,
we used the standard F1 score in the field of machine learning to measure how good a
predicted cluster is compared to a reference cluster. Suppose BioSweeper predicts p
complexes, and there are q = 203 true complexes. We can construct a bipartite graph
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with the adjacency matrix F ∈ Rp×q between these two sets of complexes whose edge
weights are the F1 score, defined as
F1 =
2TP
2TP + FP + FN
, (3.7)
where TP, FP, and FN represent true positives, false positives, and false negatives,
respectively. The MMR is in fact the maximal matching in this weighted bipartite
graph. That is to find f edges such that
∑
(i,j)∈f F (i, j) is maximized where f =
min(p, q) and only one-to-one match is allowed. Finding the optimal matching in a
weighted bipartite graph can be solved by Hungarian algorithm [172]. We downloaded
a Matlab implementation of this algorithm developed by Yi Cao from the Matlab File
Exchange at https://www.mathworks.com/matlabcentral/fileexchange/20652.
We first partition the first-layer network G in order to compare our perfor-
mance with those of MCL [112] and ClusterONE [155] using the same input pro-
tein interactome without the functional information. This experiment is denoted as
BioSweeper-1. We used a guided seeding strategy by selecting the 203 seeds with the
highest degrees within each gold-standard protein complex. After predicting 203 pro-
tein complexes by our method, we compared our predicted complexes with the gold
standard set, and achieved an MMR score of 0.3258 which is comparable with the
performance of ClusterONE with the MMR score of 0.3498, and outperforms MCL
using inflation as 3.3 (suggested by the developers of ClusterONE in their comparison)
with the MMR score of 0.2791.
We then integrated functional annotations (matrix R) and the GO hierarchy (ma-
trix H) to improve the performance of BioSweeper, which is the main contribution
of our method. This experiment is denoted as BioSweeper-2 since we used two-layer
network structure. A problem arises when we compare our predicted clusters against
the gold-standard cluster set: BioSweeper performs clustering on the two-layer net-
work and yields clusters containing the nodes in the both layers (proteins and GO
terms), but all the nodes in the gold-standard clusters are the first-layer nodes (pro-
teins). We did the comparison by removing the second-layer nodes from our predicted
clusters, and then used the graph component containing the source node to compare
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with the gold-standard cluster. This process was implemented by the Matlab function
of component detection in MatlabBGL [173]. After integrating the functional informa-
tion into our model with the parameters α = 0.99, σ = 0.35 and τ = 0.1, we achieved
an MMR score of 0.3843 which outperformed ClusterONE by almost 10%. Besides
the better performance, BioSweeper automatically detects the enriched functional
terms associated with each predicted cluster. For example, BioSweeper successfully
predicted a cluster with components: YBR254C, YDR246W, YDR407C, YDR472W,
YEL048C, YGR166W, YKR068C, YML077W, YMR218C, YOR115C, which is iden-
tical to the gold-standard complex: TRAPPII protein complex (GO:1990071). The
functional enrichment analysis verifies that the GO term, GO:1990071, is statistically
enriched in our predicted cluster (p-value = 3.27× 10−31, Fisher’s exact test).
3.3.2 Partitioning Gene Co-expression Network
With the advance of high throughput RNA-sequencing technology, identifying
gene co-expression modules is a long-term goal in systems biology. Grouping genes
with similar expression pattern together gives insight into regulatory mechanisms
between transcription factors and their target genes. WGCNA (Weighted Gene Co-
Expression Network, [61]) is one of the classical methods to detect co-expression
modules given genome-wide expression data. Here, we present how to use BioSweeper
to detect co-expression modules while integrating heterogeneous data: Hi-C genomic
contacts. This dataset represents the contact frequency between genomic regions in
the 3D spatial chromatin structure. Hi-C genomic contact data have proved to be
helpful in identification of co-factor protein complexes [174].
We construct a two-layer network with one layer as the gene co-expression network,
and the other as the Hi-C genomic contact network. We downloaded an image-based
measures of gene expression in mouse cortex from the Allen Brain Atlas [175], and an
intra-chromosomal Hi-C contact matrix from Shen et al. [176]. After gene ID mapping
using BioMart [177] and gene-to-genomic-region localization by BEDTools [178], we
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obtain m = 3, 789 genes and n = 67, 725 genomic bins (genomic regions). The number
of bins in each chromosome is listed in Table 3.1.
Table 3.1
Statistics of Hi-C Contact Data in Mouse Chromosomes
Chr. Index Chr Size No. of Bins Bin Size
chr 1 195,471,971 6182 31620
chr 2 182,113,224 6074 29983
chr 3 160,039,680 4988 32085
chr 4 156,508,116 4782 32729
chr 5 151,834,684 4522 33577
chr 6 149,736,546 4273 35043
chr 7 145,441,459 3971 36626
chr 8 129,401,213 3657 35385
chr 9 124,595,110 3507 35528
chr 10 130,694,993 3385 38611
chr 11 122,082,543 3362 36313
chr 12 120,129,022 3309 36304
chr 13 120,421,639 2854 42194
chr 14 124,902,244 2660 46956
chr 15 104,043,685 2509 41469
chr 16 98,207,768 2221 44218
chr 17 94,987,271 1970 48217
chr 18 90,702,639 1903 47663
chr 19 61,431,566 1596 38491
We calculate the Pearson Correlation Coefficient (PCC) between each pair of
gene expression profiles, and found that the PCC values are centered around 0.5
(Figure 3.2, blue distribution). Following the idea of WGCNA [61], we took the square
of each PCC value to select strongly co-expressed pairs of genes with a threshold of
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0.5 after the transformation (Figure 3.2, yellow distribution). For matrix G ∈ Rm×m
in the first-layer network, Gij = 1 if the square of PCC between gene i and j is larger
than 0.5, Gij = 0 otherwise. By setting this threshold, we obtained 426, 294 binary
edges in the first-layer network.
Fig. 3.2. Distribution of PCC and PCC Squared.
In terms of the Hi-C genomic contact data, the original Hi-C contact frequencies
range from 0 to 557.045. Since the Hi-C data are very noisy, we converted them into
binary values by setting Hij = 1 if the frequency between region (or bin) i and j
is larger than 1, and 0 otherwise. This thresholding step yields 4, 365, 209 genomic
contact measures.
For matrix R ∈ Rm×n, the gene-bin relationship, it denotes what proportion of
gene i is located in genomic bin j. One gene may span multiple bins in the genome,
and we define Rij as the overlapping length of gene i and bin j divided by the whole
gene length from the transcription start site to the end of the last exon, which means
Rij ∈ [0, 1].
We further restricted module detection to be only within each chromosome for
the following reasons: (1) the co-expression network G is highly dense, containing an
inseparable giant component without any modular structure; (2) no gene is known
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to span more than one chromosome; and (3) no Hi-C genomic contact is measured
between two regions in different chromosomes.
We highlight 3 detected co-expressed modules that meet the following criteria: (1)
the module must have more than 2 genes but less than 10 genes; (2) the module must
have more than 1 genomic regions; and (3) at least two genes in the module belong to
different genomic regions. The details of these 3 modules are listed in Table 3.2. Note
that the mouse gene annotation file is Mus musculus version 9 (mm9) downloaded
in March 2016 from UCSC Genome Database, rather than the up-to-date version 10
(mm10).
Table 3.2
Three Highlighted Modules Detected by BioSweeper




















Our multilayer network partitioning algorithm, BioSweeper, provides a joint-
clustering strategy to identify meaningful network modules via heterogeneous data
integration. The main contributions of BioSweeper can be summarized as follows.
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• BioSweeper integrates protein functional annotations into the identification of
protein complexes, which yields better predictions than ClusterONE, a state-of-
the-art method in this task, and automatically identifies the statically enriched
functional terms for predicted protein complexes.
• BioSweeper integrates Hi-C spatial genomic contact data to identify gene mod-
ules with similar expression profiles and high proximity in 3D chromatin struc-
ture, which implies a potential long-range regulatory mechanism within the
identified modules.
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4. NETWORK BALANCING: DIFFERENTIAL FLUX
BALANCE ANALYSIS
Protein fluxes provide a more refined notion of protein abundance than raw counts
alone by considering potential channels based on protein interaction networks. We
propose a novel method, namely difFBA, to estimate protein fluxes in a protein in-
teraction network using a linear programming model based on the framework of flux
balance analysis. When we combine this estimate of protein fluxes with a protein-
centric network measure, inspired by egocentric network analysis in sociology, we
discover that the fluxes of proteins encoded by hypermutated genes in colon cancer
have substantially higher rates of alteration in cancer cells than the protein quantities
alone. These alterations remain statistically significant under different network per-
turbations. We conclude that the importance of a change in the quantity of a protein
is determined not only by the protein itself, but also by its network neighbors.
4.1 Background
Systems biology is the interdisciplinary study of the cooperative behavior of bio-
logical molecules through complex interactions in a biological system. A fundamental
task in systems biology is to uncover the rules governing how molecules select their
interacting partners in a complex interaction network. Whether and how, for exam-
ple, a protein changes its friendship under different physiological conditions given a
protein physical interaction network is unclear.
High throughput technologies enable comprehensive measurements of various molec-
ular profiles that are useful for the study of complex diseases, such as cancers [179–
181]. By comparing these profiles in different conditions, one can identify both qual-
itative and quantitative molecular alterations, such as genetic mutations and dif-
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ferential protein abundance in signaling pathways, respectively. However, identical
genetic mutations are rarely identified in different patients, but rather are often found
in common signaling pathways [11,182]. Attempts have been made to investigate how
genetic variants disrupt protein interactions [15,97]. But these methods did not incor-
porate quantitative protein abundance data, and therefore cannot be used to interpret
how structurally abnormal proteins caused by genetic mutations mediate interaction
dynamics in signaling pathways.
Quantitative changes in protein interactions can be experimentally measured by
AP-SWATH (Affinity Purification combined with Sequential Window Acquisition of
all THeoretical spectra) mass spectrometry [104, 105]. However, currently the AP-
SWATH technique is limited to small-scale studies due to the insufficient precision of
statistical estimation for interacting protein abundances. And large-scale proteome-
wide studies of quantitative changes in protein-protein interaction networks still de-
pend on computational modeling. From a computational perspective, thermodynamic
or kinetic modeling has been used to offer a precise quantitative map of transcriptional
regulatory pathways [183]. However, the application scale of this method is usually
limited to less than 10 transcription factors due to its high computational cost and
the difficulty of obtaining the required kinetic parameters. In sum, both AP-SWATH
and thermodynamic or kinetic modeling only work on small-scale studies. Extending
the both methods to large-scale studies is an active research topic in systems biology
community.
Linear modeling is able to model high-throughput large-scale data sets, and is
widely used to study biological networks. Li et al. constructed a bipartite net-
work between exon fragments and transcripts to estimate transcript abundance from
mRNA sequencing data using a modified regularized least squares model [184]. Wang
et al. reconstructed a transcriptional regulatory network from multiple microarray
data sets by linear programming [185]. Duarte et al. utilized Flux Balance Analysis
(FBA), a model based on linear programming, to reconstruct a human metabolic
network [186]. However, to our knowledge, there are few studies using linear models
69
to analyze proteome-wide quantitative data in a large-scale protein interaction net-
work. In fact, FBA can be extended from metabolic networks to protein interaction
networks under reasonable assumptions (see Methods).
To this end, we propose difFBA, a linear programming model based on the FBA
framework, to estimate protein flux (for definition, see Methods) in a protein inter-
action network, and demonstrate its use on proteome-wide quantitative data in colon
cancer. In the Methods section, we make two basic assumptions to adapt the network-
based proteomic model to the framework of FBA, and then mathematically describe
the linear programming model and the egocentric network metric used in evaluation.
In the Results section, we describe the quantitative proteomic data sets; illustrate the
distribution of protein fluxes; and finally examine the predictive performance of the
estimated protein fluxes within the egocentric networks of hypermutated genes, and
also the performance robustness under different network perturbations.
4.2 Methods
Flux Balance Analysis (FBA) is widely used in metabolic networks [8]. It calcu-
lates the fluxes of metabolites through the network of biochemical reactions based on
reaction stoichiometry. Similarly, given one protein with multiple binding partners
in a protein interaction network, we would like to estimate the proportions of the
protein binding to each of its partners. This binding fraction is termed protein flux
in this study.
FBA can be viewed as a linear programming model [8]. Given a set of stoichio-
metric constraints, FBA aims to optimize a predefined objective function, e.g., to
maximize a set of fluxes. Similarly, the goal of the proposed model in this study is to
maximize the sum of all protein fluxes in the interaction network. The rationale for
this objective function lies in two facts. On one hand, many proteins cannot function
alone in a living cell. Instead, they bind to their network partners in a functional
group to fulfill biological functions in vivo. On the other hand, proteins are intrinsi-
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cally expensive to produce, and it is inefficient to produce proteins in excess of their
binding partners.
4.2.1 Model Assumption
The proposed model is subject to the following two assumptions:
• No Stoichiometry: each protein copy can only bind one single copy of its neigh-
boring proteins in the network. And the ratio of each binding pair of protein
copies is 1:1, since currently no large-scale stoichiometric data are available.
Similarly to the application of FBA in biochemical reaction networks, proteome-
wide stoichiometric data can be naturally incorporated into our FBA-based
model once they can be measured in high throughput manner.
• Independence: protein binding depends only on the abundance of the two pro-
teins. Other complicated factors like protein locations, binding affinity and reg-
ulatory mechanism are not considered in this study, since these factors cannot
be simplified into the linear structure of FBA. Instead, modeling protein loca-
tions, binding affinity and regulatory mechanism requires a spatial, high-order
and time-varying system model. Solving this complicated model is computa-
tionally expensive, and cannot be applied to large scale proteome-wide data so
far. In fact, the independence assumption is similar to assuming complete and
rapid mixing of protein copies.
4.2.2 Model Construction
The model construction starts with a protein interaction network and a list of
protein quantity data measured by quantitative proteomic techniques. We denote
the protein interaction network as an undirected graph with a symmetric adjacency
matrix G ∈ Rm×m where m is the number of proteins, and Gij = 1 (i, j = 1, · · · ,m)
if protein i physically interacts with protein j, and 0 otherwise. Then the adjacency
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matrix is converted into an incidence matrix A ∈ Rm×n where n is the number of
edges in the graph (normally m  n), and Aik = Ajk = 1 (k = 1, · · · , n) if Gij = 1
and 0 otherwise, where i < j. In fact, the incidence matrix shows the relationship
between nodes and edges in a graph. We denote the protein quantity data as a
vector b ∈ Rm and the protein flux of each interaction as x ∈ Rn. The model is
designed to maximize the total interaction fluxes, i.e., cTx where cT is an all-one
vector. The portion of bound proteins in the flux is calculated as Ax; this portion
of any protein cannot exceed its total quantity, i.e., Ax ≤ b. The estimated fluxes





subject to Ax ≤ b
x ≥ 0.
(4.1)
We empirically set the lower bound of x as 0.001 other than exact 0 for two reasons.
First, to further compare the fold change of protein fluxes in two conditions, we need
to calculate log2(x
c1/xc2), and it has no meaning when xc2 exactly equals to 0. Second,
in practice we found that, given different protein abundance b, the lower bound of x
set to a value less than 0.001 yields different boundary values in the solutions when
we use the interior point method to solve the linear programming problem.
4.2.3 Evaluation Metric
To test if differential protein flux prioritizes disease-associated genes better than
differential protein quantity, we have devised a novel protein-wise metric based on an
Egocentric Network (or EgoNet). The EgoNet of one node in a graph is defined as
a local subnetwork comprising that node, its direct neighbors and the edges among
them. In the literature of social and information networks, EgoNet analysis is fre-
quently used to identify important structural and anomalous types of nodes [187,188].
In this study, similarly, the flux changes in the EgoNet of one protein help identify
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how altered quantities affect a local network region centered at that protein. For a




∗ if (i∗, j∗) ∈ EgoNet(t);
0 otherwise,
(4.2)
where k∗ is the corresponding index of edge (i∗, j∗) in flux vector x. Under two
different conditions c1 and c2, the total flux change of a protein t within its EgoNet can
be quantified using the Frobenius norm as sE(t) (Equation 4.3). In contrast, we define
two baseline scores for protein t between conditions c1 and c2 as the total flux change
to neighbors sN(t) (Equation 4.4) and the quantity change sB(t) (Equation 4.5),
respectively as,
sE(t) = ‖Zc1(t) −Zc2(t)‖F (4.3)
sN(t) = a
T
t |xc1 − xc2| (4.4)
sB(t) = |bc1t − bc2t | (4.5)
where aTt is the t-th row of matrix A.
4.3 Results
4.3.1 Data Sets
There are two data sets needed in differential FBA. One is the protein-protein
physical interaction network, which can be downloaded from BioGRID [145]. The
other is the protein quantity data (absolute copy numbers), which is obtained from
an extensive quantitative proteome study of colon normal tissue and adenocarcinoma
[189]. After ID mapping across these two data sets using BioMart [190], we identified
6, 334 proteins with measured quantities in both conditions (normal and cancerous)
and 49, 337 physical interactions among them. Due to the large range of measured
protein quantities (102 to 108), we performed a log-scaling, as shown in Figure 4.1(A).
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Fig. 4.1. Scatter Plot of Protein Quantities (A) and Fluxes (B) in
Normal (x-axis) vs. Cancer (y-axis) Conditions.
4.3.2 Distribution of Differential Fluxes
Given the protein quantities bn in normal colon tissue and bc in colon cancer,
respectively, the linear programming model (Equations 4.1) was solved to estimate
the protein fluxes xn and xc, respectively (Figure 4.1(B)). Comparing Figure 4.1
(A) and (B), we find that majority of protein quantities and fluxes show no change
between normal and cancer conditions. However, a portion of the fluxes are close to
zero, even though their linked proteins are abundant, indicating that some of the flux
channels (protein interactions) are shut down under specific pathological conditions.
To highlight significant changes in protein quantities and fluxes, we illustrate the
distribution of log2 fold changes of the ratios of cancerous to normal conditions in
Figure 4.2. A subset of interactions show significant log2 fold changes (5+ folds)
compared to the overall log2 fold changes in protein quantities (0.2+ folds). This
suggests that the proposed model is able to correctly combine the changes in protein
quantities and interactions. In this case, one can find an associated set of interaction
fluxes that explain the change in protein quantities. For instance, given the up-
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regulation of one protein, the proposed model is able to inform us which fluxes are
concurrently up-regulated and which are not responsive or down-regulated.

































Fig. 4.2. Histogram of log2 Fold Changes (C/N, Cancer over Normal
Conditions) in Protein Quantities (A) and Protein Fluxes (B). The
most abundant fold change bin in (B), located within [−0.5, 0.5], is
truncated at 1, 500 for visualization convenience. The actual value is
43, 798 interactions.
Our FBA-based linear model is scalable for larger data sets. Using the solver,
linprog in MATLAB, it normally takes around one minute to solve the model with
our data set. We used the default algorithm in the solver, the interior point method,
which has proven to be a polynomial-time algorithm in solving linear programming
problems [191].
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4.3.3 Identification of Known Cancer Genes
To evaluate whether significant flux changes are associated with proteins related to
colon cancer, we first collected 18 hypermutated genes from a comprehensive genomic
study of colon cancer reported in The Cancer Genome Atlas (TCGA) [181]. We first
tested the null hypothesis that the cancer-related proteins with increasing (decreasing)
quantities up-regulate (down-regulate) all the fluxes to their network neighbors. For
each hypermutated gene/protein, we used a scatter plot to examine the relationship
between its quantity fold-change and flux fold-changes (Figure 4.3). Generally, we can
see that there is no positive relationship between the fold changes of protein quantity
and protein flux. This rejects the null hypothesis and suggests that an up-regulated
(or down-regulated) protein does not necessarily up-regulate (or down-regulate) all
of the fluxes to its neighbors. For example, TP53, a well-known oncogene [192], is
up-regulated by around 0.3 folds in quantity, whereas its flux fold changes span a
wide range (±8 folds) in cancer cells. Using our model, one can narrow down a
large number of fluxes into a small set, and perform further precise modeling, or
experimental validation using AP-SWATH, for example.
To further test whether flux changes in EgoNet can be used to predict these
mutated genes in colon cancer, we scored each protein using the three Equations (4.3),
(4.4) and (4.5), and examined the score ranks of these mutated genes using Receiver
Operating Characteristic (ROC) curves (Figure 4.4). The Area Under the Curve
(AUC) indicates the predictive performance of the three metrics. As shown in Figure
4.4, we find that the EgoNet-based metric achieves the AUC of 0.7327, whereas the
other two baseline scores based on the difference only of protein quantity and flux
changes to neighbors have the AUCs of 0.4759 and 0.7169, respectively. In particular,
at a 0.2 false positive rate, the EgoNet-based metric achieves a true positive rate of
around 0.55, whereas the protein quantity change and flux change to neighbors achieve
only about 0.2 and 0.45, respectively. This suggests that protein quantity changes
influence not only the fluxes flowing out to their network neighbors, but also the fluxes
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Fig. 4.3. Fold Changes of Protein Quantities (x-axis) and Fluxes (y-
axis) of 18 Hypermutated Genes in Colon Cancer.
between their neighbors. In addition, it reveals that the proteins with cancer-related
mutations have no significant changes in quantities. Nevertheless, using the proposed
differential FBA combined with the egocentric network analysis, we discovered that
genetic alterations in fact have much stronger impacts on protein fluxes within the
EgoNet than protein quantities alone.
To examine the robustness of cancer-associated protein identification, we altered
the protein interaction network and examined whether the prediction performance is
robust to network perturbation. We first randomly reassigned the protein abundance
data to different nodes in the same network, and found that the prediction perfor-
mance (Area Under the ROC curve, AUROC) dramatically drops to a random level
(Figure 4.5). Next, we tested whether our method is robust against network topology
noise by randomly removing a proportion of edges (while ensuring that every protein
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Flux Change to Neighbors (0.7169)
Flux Change in EgoNet (0.7327)
Random (0.5000)
Fig. 4.4. Receiver Operating Characteristic (ROC) Curves in the
Evaluation of Hypermutated Gene Prediction. The Area Under the
Curves (AUCs) are shown in the brackets.
has at least one edge). We find that the performance of our method drops slowly
until 30% of edges are removed (Figure 4.5). In contrast, randomly adding 10% extra
edges results in a significant decline of the performance from 0.7327 to around 0.6,
and even worse when 30% extra edges are added in (Figure 4.5). In sum, this pertur-
bation test suggests that the network topology and the protein abundance data have
strong associations with each other. Also, it demonstrates that our method is robust
to the network data even in the presence of a relatively high false positive rate.
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Fig. 4.5. Area Under the ROC Curves (AUROC) in Robustness Test
using Randomly Perturbed Networks. In x-axis, negative percent-
ages denote the proportion of edges randomly removed; positive per-
centages denote random addition of edges; and 0% denotes random
shuffle of protein abundance data. In y-axis, the bars and error bars
indicate the means and standard deviations of AUROCs from 10 re-
peated experiments under each type of network perturbations. AU-
ROC = 0.5000 (blue dashed line) indicates the performance of ran-
dom prediction; and AUROC = 0.7327 (blue solid line) indicates the
original performance of our method without network perturbation, as
shown in Figure 4.4.
4.4 Conclusion
In this paper, we have presented a computational method, difFBA, based on flux
balance analysis to estimate protein fluxes throughout the protein interaction network
subject to a balance assumption. We show that the difference in protein quantities
can be combined with the protein interactions assuming one-hop balanced diffusion in
the network. We also show that the protein flux changes within egocentric networks
have a stronger association with the genetic mutational status of the corresponding
protein-coding genes than the protein quantity changes. To our knowledge, this is the
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first attempt to extend flux balance analysis, which is widely used to study metabolic
networks, to network-based analysis of quantitative proteomic data.
In future work, we would like to incorporate multiple omic data sets into our
framework. And so far, we have assumed the stoichiometric ratio between two binding
proteins is 1:1. As stoichiometric data in vivo become more available, they can be
integrated with higher-level network information about functional modules to refine
the estimation of protein fluxes.
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5. SIDE PROJECTS
In this Chapter, I will present two side projects: an assessment study of subnet-
work detection methods, and my participation of a community-driven competition in
systems toxicology.
5.1 Assessment of Subnetwork Detection Methods
Subnetwork detection is often used with differential expression analysis to iden-
tify modules or pathways associated with a disease or condition. Many computa-
tional methods are available for subnetwork analysis. Here, we compare the results of
eight methods: simulated annealingbased jActiveModules, greedy searchbased jAc-
tiveModules, DEGAS, BioNet, NetBox, ClustEx, OptDis, and NetWalker. These
methods represent distinctly different computational strategies and are among the
most widely used. Each of these methods was used to analyze gene expression data
consisting of paired tumor and normal samples from 50 breast cancer patients. While
the number of genes/proteins and protein interactions detected by the eight methods
vary widely, a core set of 60 genes and 50 interactions was found to be shared by the
subnetworks identified by five or more of the methods. Within the core set, 12 genes
were found to be known breast cancer genes.
5.1.1 Introduction
With the advent of high-throughput measurements in biotechnology, cancer biolo-
gists are able to dissect the complicated pathology of cancers from multiple directions.
These measured molecular profiles include genetic mutations, copy number variance,
messenger RNA (mRNA) expression, microRNA expression, DNA methylation, pro-
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tein abundance, etc. [179]. However, multidimensional data also bring a tremendous
challenge to the computational biology community. What can these data tell us about
cancer? Differential analysis is a straightforward method in which differences in the
molecular profiles of tumor and normal cells are identified. These analyses rely on a
large number of samples and result in the identification of thousands of differences
in molecular profiles. How to interpret these molecular variations as a whole is still
under investigation.
Alternatively, molecular interaction data have shown powerful potential for con-
necting isolated molecular variations into a meaningful framework. These analyses
usually start with differential analysis of molecular profiles, e.g., differential gene
expression, and score the extent of the difference for each gene. Next, biological net-
work data that indicate the association of genes are collected, and then the scores
are overlaid on the network. Now the task is to extract a subset of the network, i.e.,
a subnetwork of the global network, such that the subnetwork is as small as possible
while connecting as many highly scored genes as possible. This subnetwork enriched
in differentially expressed genes can be used to discover, for example, that the up-
regulation of one gene is caused by the overexpression of its upstream regulator or
dysfunction of its suppressor.
Subnetwork detection is a crucial analysis since it is capable of linking multiple
individual molecular variations into an insightful wiring diagram showing how one
individual variation is related to the others. Many methods for subnetwork detection
have been developed. In 2002, Ideker et al. first proposed a computational model
for subnetwork detection based on simulated annealing [193]. They also proved that
subnetwork detection is an NP-Hard problem. As reviewed by Mitra et al., many
attempts have been made during recent the decade to solve this problem efficiently
using approximation algorithms [147]. Due to the diversity of subnetwork scoring
functions used by the different approximation algorithms, it is unlikely that differ-
ent programs will obtain identical or even very similar subnetworks given the same
expression and network data.
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In this study, we propose a pipeline to comprehensively evaluate the performance
of subnetwork detection methods from multiple aspects. We first select eight methods
and assess them equally using an authoritative data set of breast cancer from The
Cancer Genome Atlas (TCGA) [179]. Then we perform a differential expression
analysis using DESeq [194] and score the significance of expression change for each
gene. Next, we extract subnetworks using the eight methods and compare their
outputs based on their coverage of significant genes, network modularity, mutual
similarities, and functional enrichment. Finally, we compare their computational
costs, user friendliness, and discuss their strengths and weaknesses, respectively.
5.1.2 Results
Overview of Subnetwork Detection Methods
Over 40 computational models have been developed during the past decade based
on various algorithms, as reviewed by Mitra et al. [147], and Berger et al. [195]. We
selected eight of them (Table 5.1) for further comprehensive assessment based on
the following three rules. First, the input of the models must be a network, and an
expression set or a list of gene weights based on the expression. The models were
ruled out if they required genetic mutation data or integration of co-expression data.
Second, the selected models must be accessible either with open source code or a well-
maintained online Graphical User Interface (GUI). Third, the selected models must
represent diversity of methodology, and similar or integrative models are excluded.
We summarize the eight selected methods and discuss their advantages and limitations
in Table 5.2.
In order to perform a fair assessment, we kept the input data of the eight models
as similar as possible (see Table 5.1). On one hand, we used the proteinprotein
interaction network from Human Protein Reference Database (HPRD) [203] as model
input if there is no preloaded network data in the models. On the other hand, if the
models used their preloaded networks and output a subnetwork including genes not
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in the HPRD network, we pruned them from the subnetwork. In terms of expression
data, we first utilized DESeq to normalize the raw counts of mRNA sequencing from
TCGA breast carcinoma data set. Then we performed differential expression analysis
across the 50 case and 50 control samples and assigned each gene an adjusted p-value
for its significance of differential expression. Those p-values can be directly used as
the input for subnetwork detection, be ranked to select a seed gene set, or be converted
into a set of particular weights tailored to the requirement of the model (see Table
5.1). Next, we ran each program to detect subnetworks and tuned the parameters to
control the size of subnetworks to be approximately 1,000 genes. Finally, we obtained
eight subnetworks from the models and performed an assessment of their coverage of
significant genes, network modularity, hits of true breast cancer genes, and functional
enrichment in Kyoto Encyclopedia of Genes and Genomes (KEGG) [204] pathways
and Gene Ontology (GO) [205] terms.
Assessment of subnetwork quality
We assess the quality of subnetworks output by the eight methods from two as-
pects: coverage of significant genes and network modularity. First, we prepared
volcano plots with log2(fold change) versus log10(p-values) for each method and high-
lighted the found genes in the eight subnetworks in red, as shown in Figure 5.1. We
find that jActiveModules using Greedy Search (jAM.GR), BioNet, and NetBox cover
most of the significant genes in their subnetworks, while excluding insignificant genes.
In contrast, jActiveModules using Simulated Annealing (jAM.SA), ClustEx, and Net-
Walker cover a large number of genes regardless of their significance. DEGAS covers
more upregulated genes, whereas OptDis covers more downregulated genes.
To further examine the specificity and sensitivity of significant gene coverage of
each method, we labeled each detected gene as a positive sample for each method
and examined whether the expression p-values predict the eight subnetworks well.










































Fig. 5.1. Volcano Plots of Differential Gene Expression. The log2(fold
change) (shown in the [−6, 6] only, 99th percentile) vs. − log10(p-
values) evaluated by DESeq. The dots highlighted in red are the
genes involving in each subnetwork produced by the eight methods.
the predictability of the p-values for the eight subnetworks. From Figure 5.2, we find
that the best performer is BioNet since it achieves an area under the curve (AUC) of
0.93, the highest AUC for any method. This is particularly interesting since BioNet
does not depend on a seed gene set. NetBox achieves comparably high AUC (0.89),
but there is an obvious kink point on the curve due to the selection of input seed
genes based on p-values. The AUC of OptDis ranks the third, probably due to the
small size of the subnetwork. jAM.SA detects the largest subnetwork but does not
cover low p-value genes very well since it accepts a high p-value gene with a specific
probability in simulated annealing to avoid suboptimality. ClustEx does not perform
as well as NetBox, even though they use the same seed gene set and network data.
This is because we only consider the largest subnetwork (210 seeds out of 801 genes)
found by ClustEx as the output and discard the smaller subnetworks, which include
455 seeds.
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Fig. 5.2. ROC Curves of − log10(p-values) Predicting the Eight Sub-
networks. The numbers in the brackets are the AUCs.
To examine modularity of the eight subnetworks, we used two different measures:
Global Clustering Coefficient (GCC) [206] and Cut-Based Ratio (CBR) [207]. GCC
measures how close a subnetwork is to a completely connected graph. And CBR mea-
sures the degree to which a subnetwork consists of more edges between nodes within
the subnetwork and fewer edges between nodes inside and outside the subnetwork.
Both modularity scores were scaled to the interval [0, 1] by dividing by the maximum
quantities (Figure 5.3). We can see that the OptDis subnetwork has the highest GCC,
probably because there are many small (3 to 5 genes) fully connected modules in the
subnetwork. In contrast, the ClustEx subnetwork has the highest CBR, probably
due to the hierarchical clustering step used before growing the subnetwork within the
clusters. The subnetworks of jAM.GR and DEGAS have moderately high modularity
scores; both methods search for subnetworks using greedy strategies.
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Global Clustering Coefficient (GCC)
Cut−Based Ratio (CBR)
Fig. 5.3. Modularity of the Eight Subnetworks.
Cross-model comparison and functional analysis of subnetworks
To investigate the similarity of the eight output subnetworks detected by the dif-
ferent methods, we first performed a pairwise comparison of the subnetworks using
Jaccard similarity, in terms of nodes (Table 5.3) and interactions (Table 5.4). Sur-
prisingly, it was found that the subnetworks of BioNet and NetBox were the most
similar even though they used different subnetwork detection strategies. Methods
using similar subnetwork detection algorithms have moderate similarities in their
output subnetworks, such as jAM.GR and DEGAS. In contrast, methods with the
same input expression and network data often detect very dissimilar subnetworks, for
instance DEGAS and OptDis, and NetBox and ClustEx. The pairwise similarities of
the subnetworks suggest that the use of similar algorithms and/or similar input data
do not guarantee a similar output. This is because the different methods use different
objective functions to evaluate a subnetwork in optimization.
We tested whether the detected subnetworks contain putative breast cancer genes.
First, we collected 462 breast cancer genes from the KEGG Orthology Based Annota-
tion System (KOBAS, [208]) v2.0 functional enrichment list, which integrates Online
Mendelian Inheritance in Man (OMIM, [209]), KEGG DISEASE [204], Functional
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Disease Ontology (FunDO, [210]), Genetic Association Database (GAD, [211]), and
the National Human Genome Research Institute (NHGRI) Genome-Wide Association
Studies (GWAS) Catalog [212] disease databases. With those 462 genes as ground
truth, we calculated the precision and recall of each of the eight subnetworks (Figure
5.4) and found that the top subnetworks in identifying the true breast cancer genes
are those produced by BioNet, NetWalker, NetBox, and jAM.GR. Surprisingly, these
four methods use totally different algorithms for subnetwork detection (see Table
5.1). And NetWalker displayed its potential for predicting true disease genes, even
though its coverage of significantly differentially expressed genes was relatively poor;
this may be due to its use of random walks to diffuse information through the whole
network without any restriction to shortest paths and greedy search.











Fig. 5.4. Prediction of the 462 Breast Cancer Genes by the Eight
Subnetworks. F1 score is defined as 2 × precision × recall/(precision
+ recall).
Then we used the list of true breast cancer genes to investigate if cancer-related
genes are more likely to be detected by multiple methods. The distribution of all genes
and the breast cancer genes is shown in Figure 5.5(a) in terms of how many different
methods detect genes in these classes. We can see in Figure 5.5(a) that many genes
are detected by only a few methods, whereas a small number of genes are detected
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by almost every method. Surprisingly, the percentage of breast cancer genes in the
reported subnetworks increases with the number of methods detecting those genes,
suggesting that the genes detected by more methods are more likely to be a true
breast cancer genes. And also it suggests that an ensemble method that integrates
multiple methods may be a better way of detecting subnetworks covering more disease
genes. Similarly, we collected 2, 058 interactions enriched in breast cancer pathways
using KOBAS [208] from the KEGG pathway [204], Pathway Interaction Database
(PID, [213]), BioCarta [214], Reactome [215], BioCyc [216], and Protein ANalysis
THrough Evolutionary Relationships (PANTHER, [217]) databases. The distribution
of interactions in terms of the number of methods detecting those interactions is shown
in Figure 5.5(b). We found that no interactions were commonly detected by more
than six methods. The interactions commonly detected by more methods are slightly
more likely to be enriched in pathways related to breast cancer.
To examine functional enrichment of commonly detected genes, we used KOBAS
to annotate the 553 genes detected by at least three methods (Supplementary Table
1, available online, DOI:10.4137/CIN.S17641). The top enriched KEGG pathways of
these genes are cell cycle (hsa04110), MicroRNAs in cancer (hsa05206), and Pathways
in cancer (hsa05200), all with the corrected p-values less than 0.05. Cancers are
enriched as the topmost disease in KEGG DISEASE database with corrected p-values
less than 0.1. And the top GO terms enriched in this gene set are extracellular matrix
(GO:0031012), cell division (GO:0051301), and their relevant terms. Note that there
is no breast cancer-specific term significantly enriched in terms of pathways, diseases,
and functions.
Finally, we used Cytoscape v3.0 [218] to visualize a prominent subnetwork in
which each interaction is detected by at least five methods. This subnetwork consists
of 60 genes and 50 interactions (Figure 5.6). Within those 60 genes, there are 12 true
breast cancer genes (red border) detected by KOBAS v2.0 in the multiple databases.
Notably, the breast cancer gene Nuclear Receptor Subfamily 3, Group C, Member 2
(NR3C2), a gene encoding the mineralocorticoid receptor, was the only gene detected
89
by all the eight methods. An RNA interference (RNAi) experiment has verified
that the depletion of NR3C2 increases cell death in breast [219]. This evidence
is consistent with Figure 5.6 in which NR3C2 is downregulated in breast cancer
cells (log2(fold change) = 2.2). We also found that actin alpha 1 (ACTA1), one of
the interactors of NR3C2, was detected by five methods and was downregulated as
well. ACTA1 is a highly conserved protein responsible for cell motility and a major
constituent of the contractile apparatus [220]. This suggests that downregulation
of ACTA1 causes increased cell motility and cancer metastasis. Similarly, inhibin,
beta A (INHBA), pleiotrophin (PTN), and seven in absentia homolog family E3
(siah E3) ubiquitin protein ligase 2 (SIAH2), which were detected by seven methods,
have been experimentally verified to be associated with breast cancer development.
Overexpression of INHBA in mesenchymal cells increases colony formation potential
of breast epithelial cells [221]. PTN, a secretory cytokine, has been found to stimulate
breast cancer progression through remodeling of the tumor microenvironment [222].
Downregulation of SIAH2 has been found to be associated with resistance to endocrine
therapy in breast cancer [223].
5.1.3 Conclusion
We have performed a comprehensive assessment of a broad spectrum of state-
of-the-art methods for subnetwork detection using up-to-date gene expression data
specific for breast cancer. The key findings in this study can be summarized in the
following three main points.
• First, based on the functional enrichment analysis, the subnetworks detected by
the individual methods offer only limited information on breast cancer pathol-
ogy. However, the prominent subnetwork detected by the majority of the meth-
ods offers a very specific and relevant result that is clearly related to breast
cancer pathology. The data used here are probably as good as or better than
what is currently available for most kinds of tumors and are therefore represen-
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tative of typical situations. Even though each of the eight methods were claimed
to be effective in their original publications, based on the data sets they used,
the subnetwork detection problem still cannot be considered to be solved and
needs further investigation.
• Second, the enrichment in known breast cancer-related genes in the set of genes
identified by many independent methods suggests that investigators should use
several different methods based on different principles. For the data set used
here, we suggest that a combination of BioNet, jAM.GR, NetBox, and Net-
Walker could be used, although it is not clear that this would be true for all
data sets or types.
• Third, in terms of ease of use, some of the methods are available only as source
code, which must be compiled and installed, typically on a UNIX-based system;
this may be an obstacle for some experimental biologists. A GUI is highly
recommended for the purpose of wide use, or perhaps implementation within a
widely used system such as R.
We suggest that the definition of subnetwork needs to be refined to be some-
thing more than a simple subset of a global network. Interactome data need to be
dissected and reorganized using high-level structures, such as pathways and protein
complexes. Those interactome structures ensure that the output subnetworks are
biologically meaningful and guide subnetwork detection methods to prune a global
network without losing the important biological structures.
5.1.4 Methods
Data preprocessing
Subnetwork detection usually requires two input data sets, a gene expression data
set and a network data set. In this study, gene expression was measured by mRNA
sequencing (RNA-Seq), and were obtained from TCGA breast invasive carcinoma cat-
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egory [179]. The expression data consist of raw counts, normalized median transcript
lengths, and Reads Per Kilobase of transcript per Million mapped reads for 20, 532
genes in 50 tumor samples, paired with 50 normal samples paired with the same
patients. The network data set was downloaded from HPRD [203]. After gene ID
matching using BioNet, 7, 369 nonredundant genes remained (Supplementary Table
2, available online, DOI:10.4137/CIN.S17641) and 28, 571 interactions were recorded
among the encoded proteins after removal of self-loops and isolated interactions (Sup-
plementary Table 3, available online, DOI:10.4137/CIN.S17641). DESeq [194] was
used to normalize the raw counts and to detect differentially expressed genes between
the tumor and normal samples based on a negative binomial model. The p-values
were then adjusted for multiple testing with Benjamini-Hochberg procedure [224]
(Supplementary Table 1, available online, DOI:10.4137/CIN.S17641).
Subnetwork detection methods
Unless further specified, we used default setting of parameters for all eight models.
The input expression and network data are summarized in Table 1, and the gene and
interaction lists of the eight subnetworks are in shown Supplementary Tables 2 and 3
(available online, DOI:10.4137/CIN.S17641), respectively.
jActiveModules [193, 196] requires a weighted gene list with the weights ranging
from 0 to 1. Hence, we directly used the adjusted p-values from DESeq as the weights.
Within jActiveModules, there are two different search strategies for subnetworks: sim-
ulated annealing [193] and greedy search [196]. For simulated annealing, we increased
the default number of iterations from 2, 500 to 10, 000. Default parameter settings
were used for greedy search. For both kinds of searches, we set the maximum number
of modules as 1.
DEGAS [197] has multiple optional algorithms, and we used the CUSP (Covering
Using Shortest Paths) heuristic algorithm to detect subnetworks. Dysregulation di-
rection was selected to be DIFF, and maximum number of modules was set to 1. The
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number of covered genes k was set to increase from 100 to 1, 000 with a step size of
100. The other parameters were kept at their default values.
BioNet [198] requires the raw p-values (not adjusted for multiple testing) as the
input from differential expression analysis by DESeq. Intrinsically, BioNet first aggre-
gates two lists of p-values from two pairs of comparisons (case 1 vs. control and case
2 vs. control) into one list. Since we only had one comparison between tumor and
normal samples, we input one more replicate list of p-values to meet the requirement.
We set the False Discovery Rate (FDR) cutoff as 0.00001 other than the default value
0.001. A low FDR cutoff has effects on reducing the size of an output subnetwork.
NetBox [199] is provided with a preloaded Human Interaction Network, and there-
fore, the only input data needed are a list of seed genes. We used only the genes with
the p-value less than 0.0001 in the differential expression analysis as the seed gene
set, which selected 1, 063 (14.4%) out of 7, 369 genes. The shortest path threshold
was set to 2 rather than the default value 1.
ClustEx [200] provides preloaded network data and also supports customized net-
work uploading. For comparative purposes, we used the trimmed HPRD network
described above. It also requires a seed gene set; we used the same set used with Net-
Box. We considered only the largest output cluster (801 genes) as the final output
subnetwork, since all the other 354 clusters contained less than 40 genes.
OptDis [201] needs three input data sets: a network, a gene expression profile,
and a gene ID conversion list linking the network and expression sets. As shown in
Table 5.1, OptDis ran slowly. To keep the computational cost tractable, we set the
maximum size of modules to 10. OptDis returned 50 modules, all with sizes less than
10 genes. We consider the union of these modules to be a single subnetwork in our
analysis.
NetWalker [202] has a preloaded network database called the NetWalker Inter-
actome Knowledgebase (NIK). After matching our 7, 369 genes with the 13, 328
genes in the preloaded network, we obtained 7, 354 matched genes. NetWalker re-
quires an expression ratio for each gene centered around 1. We defined the ra-
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tio as r = 2 · logit(log2(FC)), where FC denoted the fold change of gene expres-
sion in tumor over that in normal cells, and the logit() function was defined as
logit(x) = 1/(1 + exp(x)). The unmatched genes were assigned expression ratios of
1, denoting no significant expression change. After running, NetWalker returned an
Edge Flux value ranging from 10.04 to 2.41 for each of the 327, 599 interactions in
the preloaded network. We selected 2, 210 (0.67%) interactions with the values lower
than 5.5 or higher than 1.5 as the output subnetwork. Then the interactions not
present in the HPRD network were removed, and there remained 795 interactions as
the final subnetwork produced by NetWalker.
Subnetwork quality assessment and functional enrichment analysis
Majority of network analysis and graphing were done using MATLAB. And the
functional enrichment analysis of subnetworks was performed by KOBAS v2.0 [208].
We identified 462 breast cancer genes out of the 7, 369 genes (Supplementary Ta-
ble 2, available online, DOI:10.4137/CIN.S17641) in multiple disease databases us-
ing KOBAS, and used them as the ground truth to evaluate the predictability of
the eight subnetworks (see Figures 5.4, 5.5(a), and 5.6). Similarly, we combined the
462 breast cancer genes with 227 genes enriched in cancer pathways to query the
HPRD network and found 2, 058 interactions (Supplementary Table 3, available on-
line, DOI:10.4137/CIN.S17641) that connect the 689 genes in the querying list as a
positive set of breast cancer pathways (see Figure 5.5(b)). For the functional anal-
ysis of commonly detected genes by at least three methods, we input those genes in











































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Percentage of Breast Cancer Genes
(a) Commonly Detected Genes.

























Percentage of Breast Cancer Pathways
(b) Commonly Detected Interactions.
Fig. 5.5. Number of Methods Detecting Breast Cancer Genes and
Interactions in Subnetworks. Histograms of the number of genes (a)
and interaction counts (b) versus the number of methods that detect
them. (a) All genes denote the 7, 369 genes in the HPRD network.
Breast cancer genes are the 462 genes found by KOBAS in multiple
disease databases. Both the gene counts are scaled to [0, 1] by dividing
by the maximum count. The percentage of breast cancer genes is the
breast cancer gene count divided by the count of all the genes in
each category (genes found by a certain number of methods). (b) All
interactions denote the 28, 571 interactions in the HPRD network.
Breast cancer pathways are the 2, 058 interactions found by KOBAS
in multiple pathway databases. Both the interaction counts are scaled
to [0, 1] by dividing by the maximum count. The percentage of breast
cancer pathways is the interaction count in breast cancer pathways











































Fig. 5.6. Prominent Subnetwork Whose Interactions are Detected
by at least Five Methods. Node color indicates log2(fold change) of
differential expression (yellow: upregulated in tumor samples; blue:
downregulated in tumor samples). The 12 genes in red border are in
the list of 462 known breast cancer genes. Visualized by Cytoscape
v3.0 [218].
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5.2 SysTox Challenge: Classification of Smoking Exposure
In this challenge, we are tasked to predict smoking exposure (smoker vs. non-
current smoker) or cessation (former smoker vs. never smoker) status using gene
expression data of human whole blood. The expression data, measured by microar-
rays, consist of 18, 604 genes in 224 samples for training and 1, 340 samples for testing.
Each samples are labeled as smoker, former smoker or never smoker. Generally, this
task can be considered as a classical classification problem in machine learning. We
employ three state-of-the-art classification methods to fulfill this task: Support Vec-
tor Machine (SVM), Random Forests (RF) and Artificial Neural Networks (ANN).
As a result, we report that SVM is the best performer again RF and ANN in two-fold
cross validation.
5.2.1 Introduction
Smoking is a primary risk factor for the development of various diseases, such as
lung cancer [225], Alzheimer’s disease [226], Parkinson’s disease [227], coronary heart
disease [228], inflammatory bowel disease [229], and so on. There are thousands
of chemicals in cigarettes. Some of those chemicals can enter the blood circulatory
system, which provides a way to monitor the smoking exposure of an individual
subject using gene expression of whole blood.
The whole challenge consists of two parts: sub-challenge 1 for human samples,
and sub-challenge 2 for mouse samples. In particular, sub-challenge 2 aims to verify
whether the human gene signatures derived in sub-challenge 1 can be used to predict
smoking exposure status in mouse samples. In this section, we report only the result
of sub-challenge 1 in predicting smoker
There are three given data sets, one for training and the other two for testing. All
the expression data are generated by microarrays consisting of 18, 604 human genes
and their expression in 224 training samples with labels, and 1, 340 testing samples
without labels (638 and 702 samples for round 1 and 2 tests, respectively). The
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expression intensities are positive continuous values less than 20. We divided them
by 20 to scale them into [0, 1] before feeding them into the classifiers.
5.2.2 Methods: SVM, RF and ANN
Support vector machine, random forests and artificial neural networks are all
classical machine learning methods with many successful applications in various fields
of studies.
Support Vector Machines
Support vector machine (SVM) seeks a classification boundary with maximum
margin between different classes of objects. The boundary is, in fact, determined by
a set of support vectors (SVs), i.e., the set of objects closest to the boundary. This
makes SVM a robust classifier to outliers, since non-SV objects far away from the
boundary do not contribute to the determination of the boundary, and therefore do
not affect the final classification accuracy. For more complicated cases where two
classes of objects are not linear separable, SVM can adapt to these non-linear cases
by integrating various kernels in order to map the original feature space to a higher-
order separable space. The most complicated case is that the objects are still not
separable after being mapped to a high-order space using kernel trick. The current
standard version of SVM overcomes this challenge by introducing soft margin which
can tolerate a small portion of classification errors. This idea was proposed by Corinna
Cortes and Vladimir Vapnik in 1993 and was published in 1995 [230].
Random Forests
Random forest (RF) is an ensemble learning method that applies a voting strategy
to the classification results of many individual decision trees. It is simple to obtain
a satisfying and robust result using RF, since the only parameter to tune is the
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number of trees. Normally, the more trees we grow, the better results we have.
Remarkably, RF is resistant to overfitting [231], which is an advantage compared to
neural networks, when the number of samples is much smaller than the number of
features. RF performs a bootstrap sampling from the training set to grow each tree,
which lowers the correlation among the trees and maximizes the forest diversity so as
to decrease overfitting. This advantage makes RF one of the most popular classifiers
in molecular diagnosis, since the number of patients is normally less than the number
of measured genes.
Artificial Neural Networks
Artificial Neural networks (ANN) and its extension, Deep learning, are a bioin-
spired model that mimics how brains recognize objects and memorize information. It
is a much more suitable approach for big data challenges than SVM and RF due to
its versatile infrastructure of hidden neurons. Its successful applications span various
fields of study in artificial intelligence, such as image classification, speech recogni-
tion, and recently, computer gaming (see AlphaGO [232]). Deep learning rebuilds
the fame of ANN by avoiding overfitting using advanced techniques such as max-
pooling (induction, [233]) and dropout (like amnesia, [234]). One of its extensions,
a deep convolution neural network (CNN) with 8 layers of neurons, trumped SVM
in image classification under the standard test using the largest image database, Im-
ageNET [235] with an error rate of 15.3% (CNN) compared to 26.2% (SVM) on
October 13, 2012. This is just the beginning of the deep learning era. However,
training a deep neural network is computationally expensive, since there are many
free parameters corresponding to the connections within and between the layers of
hidden neurons.
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5.2.3 Results: Two-fold Cross Validation
We randomly split the given training samples into two sets, each of which consists
of 112 samples. Then we trained the three classifiers using one set and tested their
performances using the other, then we switched the two sets for a two-fold cross
validation.
For SVM, we downloaded LIBSVM, A Library for Support Vector Machines [236],
from the website: https://www.csie.ntu.edu.tw/~cjlin/libsvm/. This library
provides users with four different kernels: linear, polynomial, radial basis, and sig-
moid. We tested the performances of these four kernels using two-fold cross valida-
tions with 3 repeats. The result demonstrates that the linear kernel has the best
performance (Figure 5.7), since the feature space is already very high, and therefore
non-linear kernels contribute little to the prediction.
SVM Kernels















Fig. 5.7. Performances of SVMs with Different Kernels. The error
bars represent the standard deviations of prediction errors from 5
repeats of cross-validation experiments.
For RF, we used the MATLAB built-in toolbox, TreeBagger to conduct the ex-
periment. More details about this toolbox can be found from the official website:
http://www.mathworks.com/help/stats/treebagger.html. We tested the perfor-
mances of RFs with different number of trees, 10, 100, and 1000, respectively, and
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examined whether more trees resulted in overfitting. Based on our experimental
setting, the result confirms Leo Breiman’s claim that RF is resistant to overfitting
(Figure 5.8). The prediction error keeps decreasing as the number of trees increases.
















Fig. 5.8. Performances of RF with Different Trees. The error bars
represent the standard deviations of prediction errors from 5 repeats
of cross-validation experiments.
For ANN, we downloaded a Matlab deep learning toolbox written by Rasmus Berg
Palm from his GitHub: https://github.com/rasmusbergpalm/DeepLearnToolbox.
Even though we utilized several techniques developed for deep learning to avoid over-
fitting during our model training, we constructed a traditional ANN with only two
hidden layers with 100 neurons at each layer (Table 5.5), due to the small size of our
training date. Thus, we consider our ANN as a shallow network other than a deep
neural network. The detailed setting of our ANN model is listed in Table 5.5.
The fraction of dropout means we randomly shut down a hidden neuron with a
certain probability (0.25 is used in our model) to avoid overfitting during training
[234]. The sigmoid function is a commonly used activation function in ANN and
deep learning, even though many other activation functions have been developed in
the past 10 years. The learning rate, ranging from 0 to 1, represents the step size of
the stochastic gradient descent (SGD) search. A small learning rate can help capture
the optima at the expense of slowing down the search. Setting the learning rate as 1
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Table 5.5
Parameter Setting of ANN
ANN parameters Setting
Number of hidden layers 2




Number of epochs 25
Batch size 35
in our model saves our computational time, but does not guarantee the training error
to reach the optima in our experiment (Figure 5.9). The number of epochs denotes
how many times the data propagate throughout the entire ANN during training. And
the batch size is a parameter of SGD indicating the sample size of a mini-batch over
which the gradient is averaged.
Figure 5.9 illustrates one of our training experiments using the parameter setting
listed in Table 5.5. The training error quickly reaches almost zero after 25 epochs.
However, a training error of zero in ANN does not guarantee an equally perfect error
rate in testing.
Taken together, we put the best performance of each method into Figure 5.10 for
comparison. We found that SVM with linear kernel is the best performer over RF
and ANN, with an averaged testing error of 12.65%. RF with 1000 trees has the
most stable performance with an averaged testing error of 17.86% and the smallest
standard deviation. ANN does not perform as well as SVM and RF due to overfitting
with an averaged testing error of 21.13%.
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Number of Epochs in ANN





























Fig. 5.10. Performance Comparison of the Three Methods. The error
bars represent the standard deviations of prediction errors from 5
repeats of cross-validation experiments.
5.2.4 Conclusion
We utilize three state-of-the-art classification algorithms to predict whether an
individual is a smoker or non-current smoker using the gene expression data in whole
blood. Our experiment demonstrates that SVM with a linear kernel is the best tool in
a two-fold cross validation with 224 samples and 18, 604 features. We conclude that
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SVM and RF still have competitive performance in small data sets, whereas deep
learning requires large data sets to release its power.




In this thesis, I have developed three computational tools to label, partition,
and balance molecular networks, respectively. The results suggest that integrating
heterogeneous datasets into molecular networks can provide deeper insight into the
functional organization and behavior of biological molecules. Raw data of molecular
networks offer limited information for scientists to understand complex functional
behaviors. Those data show only which molecules directly interact with each other,
but they cannot be used to answer the following questions: (1) why are they con-
nected to each other, (2) how does the connection play a role in a complex biological
process, and (3) how does the connection change in different physiological conditions.
The success of AptRank in protein function prediction validates the hypothesis that
proteins with similar functions tend to interact with each other. BioSweeper reveals
the functional organization of molecule networks, and demonstrates how a team of
molecules performs a complex process by their connections. DifFBA uncovers con-
nections are not constant but dynamic, and these changes provide more insight in
understanding the molecular mechanism of phenotypic formation than the changes of
molecular quantities alone.
6.2 Future Direction
6.2.1 All-in-One: Differential Pathway Analysis (DiPAna)
In the future, I will incorporate the three models developed in this thesis, Ap-
tRank, BioSweeper and difFBA, into a unified model to perform Differential Path-
way Analysis (DiPAna) using quantitative proteomic data from complex diseases.
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In particular, I will first use AptRank to obtain a “full” protein functional profile
given the incomplete functional annotations. Next, with the “full” functional profile,
BioSweeper will detect functionally enriched modules (protein complexes and path-
ways) which set up the boundaries of protein fluxes in a protein-protein interaction
network. Finally, I will generalize difFBA into a non-negative least squares model,
and solve it by robust regression algorithms to obtain a pathway-activity score for
each pathway. A differential analysis of this score between case and control samples
will indicate the extent to which a pathway is perturbed in diseased conditions, which
can highlight the pathways of interest for further pathological study. Interestingly,
dipana in Italian means disentangle, which fits the function of DiPAna: to disentangle
a molecular network into a dynamic modular diagram.
6.2.2 Perspective
In terms of biology, I believe that molecular networks are the language of molecular
function, but our current network models are still insufficient to explain complicated
biological processes. Integrating heterogeneous data is one of the most powerful
ways to enrich molecular networks. As more and more data on DNA methylation,
non-coding RNA expression, protein post-translational modification and metabolic
profiling become available, it will one day be feasible to construct a global molecular
map of an advanced organism. To come back to the ultimate question: why does one
molecule choose to interact with another? This question cannot be answered without
the light of evolution. Evolutionary game theory attempts to answer this kind of
question: why does one molecule decide to act cooperatively, and does the disruption
of this molecular cooperation lead to diseases. Are molecules selfish?
In terms of computer science, current advanced machine learning methods enable
automatic image classification, language translation, speech recognition and many
other complicated tasks. However, those techniques are still too young to understand
the world of biology. For example, using deep learning can successfully find a cat in
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tons of images, or even videos. However, to identify causal genetic mutations from
genomic data to facilitate disease diagnosis is still a daunting challenge for current
artificial intelligence. Genomic medicine is becoming one of the most challenging
stages for scientists in artificial intelligence. And undoubtedly, finding an efficient
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